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hindered ααAA are β-strand mimics and are likely to interact with the amyloid 
hydrophobic core based on “like likes like” residue relationships. Amino acid 
symmetrical anhydride method was employed for the peptide synthesis. It was observed 
that Fmoc amino acid symmetrical anhydrides were efficient and readily available 
reagents for acylation of the N-terminus of highly hindered ααAAs. Comparison of a 
variety of coupling protocols showed that the symmetrical anhydride method always 
provided the superior results. Amyloid fibril inhibitor AMY-1 was synthesized and 
examined for its biological activities. It was observed that AMY-1 could significantly 
reduce the aggregation of amyloidogenic Aβ10-35 at different ratio at either room 





1.1 A Brief Overview of Proteins and Peptides 
Proteins, one of the most abundant classes of biomolecules in cells, are present in 
virtually all life forms. The term “protein” is derived from the Greek word “proteis”, 
which means “first rank of importance”. In biological systems, proteins play a key role 
in a variety of chemical and physical processes. They function as enzymes which 
catalyze biological reactions in organisms; they act to transport and store biologically 
important substances such as oxygen, metal ions, and lipids. In the form of muscle fibers 
and other contractile organisms, proteins create and regulate mechanical motion of 
numerous biological activities. The many functions of proteins can be understood only in 
terms of protein structure. Proteins are linear polymers of amino acids, which are linked 
by amide bonds, also called peptide bonds (Figure 1.1). The low molecular weight 
polymer of amino acids is termed peptide. The chemical nature and sequential order of 
amino acids, and length of a peptide chain determine the characteristic structure of a 
protein and a peptide, upon which its biological functions are based.  
There are twenty standard amino acids which are commonly found in protein and 

















Figure 1.1 Peptide bond between amino acids. 
 1 
forms of some amino acids, such as α-aminoisobutyric acid (Aib, Figure 1.2),1.1-1.4 a 
prototype of Cα,α-disubstituted amino acids (ααAAs). Due to their structural features, 
incorporation of ααAAs into peptides imposes considerable constraints on the peptide 
backbone, and thus may induce specific conformations.1.5-1.8 This chapter will present an 
overview of peptide secondary structure and modification of peptide secondary structure 








Figure 1.2 Structure of α-aminoisobutyric acid. 
 
1.2 Peptide Primary and Secondary Structure 
 Peptides are unbranched polymers of amino acids. The order in which amino 
acids are found in a peptide chain is called the peptide primary structure. The primary 
structure distinguishes a peptide from other peptides and fundamentally affects all the 
chemical and biological properties of the peptide. With 20 common amino acids 
available at each residue position, it is easy to form a huge number of peptides with 
different sequences. The peptide linkage is the peptide bond (Figure 1.1), formed 
between a carboxyl group of one residue and an amino group of another residue. The 
peptide C-N bond has partial double bond character due to resonance, which restricts 
free rotation around the peptide bond (Figure 1.3, ωi = 0 or 180).1.9 Peptide backbone 
 2 
structure can be described in terms of the dihedral angles between adjacent planar 
peptide groups (Figure 1.3).1.9 Rotation about the Cα-N bond is denoted by dihedral 
angle φ, where rotation about the Cα-C is denoted by dihedral angle ψ. Rotation of φ and 
ψ are restricted due to steric interference between non-bonded atoms. In any case, the 


















Figure 1.3 Dihedral angles of the peptide backbone. 
 
There are several different types of noncovalent forces involved in stabilizing peptide 
conformations. The primary force is hydrogen bonds. Others include hydrophobic 
interactions, electrostatic bonds and van der Waals forces. Through hydrogen bonding 
between amino acid residues, the peptide chain can arrange itself into distinctive patterns, 
and such a characteristic structure is called peptide secondary structure. Peptide secondary  
 3 
Table 1.1 Typical dihedral angles for common peptide secondary structures. 
Conformation   Dihedral angle (degree) 
       φ                            ψ 




    -57 
 
     -47 
 
         3.6 
Right-handed 310-helix     -49      -26          3.0 
Anti-parallel β-sheet     -139     +135          2.0 
Parallel β-sheet     -119     +113          2.0 
Type I β-turna     -60 (-90)     -30 (0)          3.0 
Type II β-turna     -60 (+90)    +120 (0)          3.0 
a For β-turns, the dihedral angles from two consecutive amino acids in the middle of the 
  turn are used to define the structure. The 1st angle is for the i + 1 residue and the second 
  number in parenthesis is the i +  2 residue of the turn. 
 
 
structure can be divided into three general categories, helix, β-sheet, and β-turn, where 
each conformation has its characteristic dihedral angles (Table 1.1).1.10 
 The right-handed α-helix is the most prevalent helical structure and accounts for 
approximately 31% of the residues in known globular proteins.1.10 The α-helical 
structure is stabilized by intramolecular hydrogen bonding between the carbonyl oxygen 
of each residue and the NH of the fourth residue along the chain (Figure 1.4). These 
hydrogen bonds have a length of about 2.86 Å from the oxygen to the nitrogen and are 
nearly parallel to the helix axis. Right-handed α-helices range in size from 4 to 40 
residues. There are 3.6 residues per turn and each residue extends 1.5 Å along the helix 


































































α-Helix 310-Helix  
 
 
Figure 1.4 Hydrogen bonding patterns in α-helix and 310-helix. 
 
 5 
one of the common forms is 310-helix.   The 310-helix accounts for about 10% of all 
helical structures in proteins and it is usually located at the ends of α-helices.1.11-1.12  
In 310- helices there are 3 residues per turn and 10 atoms per ring formed between the 
hydrogen-bonded amide proton and carbonyl oxygen (Figure 1.4). The packing of the 
backbone atoms in 310-helices is very tight and they typically have less residues on 
average than α-helices. 
 After the α-helix, the second most abundant structural element in proteins is the 
β-sheet. There are approximately 28% of the residues in recognized globular proteins are 
found in β-sheets.1.10, 1.13 The β-sheet conformation depends on intermolecular hydrogen 
bonding between the nearly fully extended peptide chains, called β-strands. In all 
recognized β-sheets, the β-strands have a twisted conformation and can be considered as 
a special helix with 2.0 residues per turn and a translation of 3.4 Å per residue. The β-
strand conformation is stable only when incorporated into β-sheet where it forms 
hydrogen bonds with peptide groups on neighboring strands (Figure 1.5).  
 The β-sheet can exist in two varieties: parallel and antiparallel β-sheet. In a 
parallel structure the neighboring peptide chains are aligned in the same N-to-C terminus 
direction, while in an antiparallel structure the neighboring peptide chains are aligned in 
an opposite direction as shown in Figure 1.5. β-sheets can consist of pure parallel or 
antiparallel strands or can have a mixture of the two strands.1.10 β-sheets are important 
structural elements in both fibrous and globular proteins. Many proteins, including 
carbonic anhydrase and glyceraldehyde phosphate dehydrogenase, contain both α-
























































































Figure 1.5 Hydrogen bonding patterns in β-sheets. 
 
 The third common form of peptide secondary structure is called β-turn. β-Turn is 
an important component of protein structures and it comprises nearly 25% of the 
residues of globular proteins.1.10, 1.15 A β-turn involves four consecutive residues and it 
reverses or folds back the peptide chain by nearly 180 degrees. β-Turns are often 
stabilized by a hydrogen bond between the carbonyl oxygen of residue i and amide 
proton of residue i + 3 (Figure 1.6). There are two common types of β-turn, type 










Figure 1.6 Hydrogen bonding pattern in a β-turn. 
 
 are mirror images of the backbone of type I and type II β-turn, respectively. In protein 
structure, type I and II β-turns occur more frequently than variants type I’ and II’, though 
the type I’ is generally located in β-hairpins.1.10, 1.15 
1.3 Cα,α-Disubstituted Amino Acids and the Promoted Peptide Secondary 
Structure 
 
1.3.1 α-Aminoisobutyric Acid 
Cα,α-disubstituted amino acids (ααAA) are a class of non-coded amino acids in 
which the presence of two substitutents (usually alkyl groups) at the α-carbon imposes 
intense constraints on the φ/ψ angles of the residue (Figure 1.7). The most commonly 
studied ααAA is certainly  α-aminoisobutyric acid (Aib). Aib is a naturally occurring 
amino acid produced by microbial sources,1.1-1.4 typically by non-ribosomal peptide 
synthesis. It is known that Aib residues have dramatic influences on peptide backbone 
conformation.1.16-1.20 In an Aib residue, the rotation about N-Cα and Cα-C’ bond is 
restricted. The energy minimum for the dihedral angle φ and ψ of Aib occur near –57º,  
-47º and 57º, 47º respectively, which corresponds to a right-handed or left-handed α-





Aib    R = methyl       Deg    R = ethyl
Dpg   R = propyl        Dbzg   R = benzyl  
 
 
Figure 1.7 Representative Cα,α-disubstituted amino acids. 
 
structure by Fox and Richards showed this Aib-containing peptide adopted a mixture of 
310- and α-helical structures in the solid state.1.23 Since the 1980s, a number of groups 
such as Balaram’s and Toniolo’s group, have done extensive studies on Aib peptide 
conformation.1.16, 1.18-1.19 Studies have shown that Aib peptides can adopt α, 310 or α/310-
helical structures depending on sequence length, Aib content, and solvent effects.1.7, 1.18, 
1.24 It has been reported that the minimal length for a peptide to form an α-helix is seven 
residues, while no significant chain length is required for 310-helix formation. Peptides 
with more than 8 residues are more likely to adopt an α-helix than a 310-helix, if the Aib 
residue content is not more than 50%. Meanwhile, even a single α-helix chain often has 
310-helices present at either end of the stretch which tightens up the ends of the α-helix 
structure.1.10 It has been found that solvents also effect the conformational preference of 
Aib rich peptides.1.5, 1.7, 1.25 In peptides where the α/310-helix equilibrium exists, solvents 
with high polarity usually favor the α-helix formation, while the 310-helix is often found 
in low polarity solvent systems. 
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1.3.2 Cα,α-Disubstituted Amino Acids with Large Side Chains 
 In peptides containing Cα,α-disubstituted amino acid residues, the range of 
accessible backbone conformation is greatly restricted. Conformational energy 
calculation of the higher alkyl analogs of Aib, such as Cα,α-diethylglycine (Deg) and 
Cα,α-dipropylglycine (Dpg), shows that the fully extended conformation (φ ∼ ψ ∼ 180º) is 
more energetically favorable than 310/α-helical conformation (Table 1.2).1.26-1.27 
 
Table 1.2 Minimum energy conformations for Deg and Dpg derivatives. 
Compound   Dihedral angle (degree) 







    -179.5 
      55.5 
 
     -179.4 










     -179.3 
     -57.5 
    
      -178.6 







a Conformational energies are expressed ∆E = E – E0, where E0 is the energy of the most 
  stable conformation. 
 
 
 Early structural studies of short homopeptides containing Deg or Dpg showed the 
extended conformation in peptide crystal structure, was consistent with theoretical 
findings.1.26-1.29 In the structural analysis of a biologically active peptide analog, N-
formyl-Met-Dpg-Phe-OMe, Dentino et al also observed an extended backbone 
conformation at the Dpg residue.1.30 However, there is growing body of evidence 
showing that Dpg residues can adopt helical conformation, especially in heteromeric 
peptides.1.31-1.33 For example, in the peptide Boc-Gly-Dpg-Leu-Val-Ala-Leu-Aib-Val-
Ala-Leu-OMe, the dihedral angles φ and ψ at the Dpg residue are -51º and -47º 
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respectively, corresponding to an α-helical conformation.1.34 Interesting, in the single 
crystal of peptide Boc-Leu-Dpg-Val-OMe, both helical and extended conformation were 
found at Dpg residue.1.35 In fact, the energy difference between an extended and helical 
structure at a Dpg residue is context dependent and affected by sequence composition 
and length, and other residues’ preference for helical or extended structure. 
1.4 Solid-Phase Peptide Synthesis 
Solid-phase peptide synthesis (SPPS) involves anchoring a peptide chain to an 
insoluble polymeric support and extending the peptide chain by stepwise addition of a 
series of amino acid residues. Introduced by Merrifield in 1950s,1.36 the SPPS method 
has evolved  over the past five decades and has become the primary  route for peptide 






























 stepwise addition of Nα-protected amino acid residues in the C → N direction (Figure 
1.8). There are several major types of coupling reagents utilized for the carboxy 
activation process. The most commonly used reagent is 1,3-dicyclohexylcarbodiimide 
(DCC, see Figure 1.9). In the presence of a carbodiimide reagent, an Nα-protected amino 
acid forms an activated O-acylisourea which undergoes aminolysis to form a peptide 
linkage and dicyclohexylurea (DCU). A water-soluble carbodiimide, 1-ethyl-3-(3’-
dimethylaminopropyl)carbodiimide hydrochloride (EDCI), is also a commonly used 
coupling agent. The EDCI produces a soluble urea derivative which can be easily 
removed by an aqueous wash step.1.37 Carbodiimide-mediated couplings can be 
enhanced by the presence of a coupling additive, such as 1-hydroxybenzotriazole 
(HOBt) and 1-hydroxy-7-azabenzotriazole (HOAt).1.38-1.39 Such additives reduce side 



















Figure 1.9 Carbodiimide reagents and coupling additives. 
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 During the last twenty years, a number of uronium and phosphonium salts based 
upon HOBt and HOAt have been developed. Examples in these categories include O-(7-
azabenzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HATU),1.39 O-
(7-azabenzotriazol-1-yl)-tris(dimethylamino)phosphonium hexafluophosphate (AOP),1.40 
1-benzotriazolyoxytris(pyrrolidino)phosphonium hexafluorophosphate (PyBOP),1.41 and 
7-azobenzotriazolyoxytris(pyrrolidino)phosphonium hexafluorophosphate (PyAOP).1.42 
Normally, these reagents are used in the presence of an equimolar amount of the acid, 
with a tertiary amine in solvents such as DMF and acetonitrile. In general, these reagents 
are found to be highly efficient in peptide couplings typically without any appreciable 


































Figure 1.10 Uronium and phosphonium salts based on HOBt and HOAt. 
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 Mixed anhydride activation protocols are another common alternative for peptide 
bond formation. This method involves aminolysis of an anhydride formed between a Nα-
protected amino acid and another acid moiety, such as bis(2-oxo-3-
oxazolidinyl)phosphinic chloride (BOP-Cl) and 2-ethoxy-1-ethoxycarbonyl-1,2-
dihydroquinoline (EEDQ).1.43-1.44 Additional coupling protocols or reagents that have 
been applied for peptide assembly include the amino acid halides and azides.1.45 In these 
methods, the activated acids can be prepared and purified prior to coupling or formed 
more conveniently in situ by reagents like cyanuric fluoride to give acid fluorides. 
























X = F, Cl
 
 
Figure 1.11 Alternate coupling reagents for peptide assembly. 
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1.5 Peptide Structure Analysis 
Peptide structure analysis is the characterization of peptide three-dimensional 
structures by which peptide biological properties or mode of activities can be deduced. 
There are several experimental techniques such as X-ray crystallography, solution 
nuclear magnetic resonance (NMR) spectroscopy, circular dichroism (CD) spectroscopy, 
and Fourier transform infrared spectroscopy (FTIR) that have been developed for 
structural analysis of peptides. 
The X-ray crystallography was widely used to detected peptide three-
dimensional structure in the early years. The X-ray detected structure could provide 
detailed information such as bond length and bond angle in a quantitative way. Multiple 
X-ray analyses of a peptide can elucidate a finite number of conformational classes 
accessible to a peptide.1.47 However, difficulties in crystalline sample preparation and the 
conformational difference between peptides in the solid state and its form in biological 
environments limit the wide application of X-ray crystallography to peptide structure 
evaluation.  
Solution NMR spectroscopy is a powerful tool for protein and peptide structure 
sanalysis. The NMR studies use noncrystalline samples and the solution conditions can 
be varied over a wide range. The NMR input for peptide conformational study mainly 
depends on nuclear Overhause effects (NOE) and coupling constants. A NOE detects 
interproton distances of 5Å or less, while the coupling constants reflects torsion angles. 
The measured NOEs and coupling constants are collected and converted to proton 
distances and torsion angles, which are indicative of certain peptide secondary structure. 
Typically, the whole set of NOE constraints are utilized in certain computational 
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programs to search for the entire conformation space, from which the optimized solution 
structures of the peptides are obtained. 
Circular dichroism (CD) spectroscopy is a commonly used method for 
identifying peptide conformation in solution. In general, the bands in the far-UV region 
(180-250 nm) of a CD spectrum are indicative of peptide secondary structures, while the 
bands in the near-UV region (250-350 nm) often reflect the contribution of certain 




1  100% α-helix 
2  100% β-sheet 
3  100% random coil 
 
Figure 1.12 CD spectra of typical peptide secondary structures. 
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CD spectra for major types of peptide secondary are illustrated in Figure 1.12.1.50 An α- 
helix exhibits two negative CD bands around 207 nm (π→π*) and 222 nm (n→π*) and a 
positive band around 192 nm (π→π*). The β-sheet has two characteristic minima at 197 
nm and 216 nm respectively, however, even a single negative band at 216 nm is often a 
good indication of β-sheet content. The CD spectra of random coils usually display a 
large negative band near 196 nm. 
Fourier transform infrared spectroscopy (FTIR) is an alternate technique for 
peptide conformational studies. The major input of FTIR is the measurement of N-H 
band and the amide I band which are correlated with secondary structures.1.51 The FTIR 
data measurement is complementary to that of NMR and CD, and it has been used to 
examine peptides that tend to aggregate.1.52-1.53 
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 The incorporation of non-proteinogenic Cα,α-disubstituted amino acid (ααAA) 
residues greatly restricts the range of the peptide accessible backbone conformation and 
thus induces distinct secondary structures even in short peptides.2.1-2.7 The most 
commonly studied ααAA is certainly α-aminoisobutyric acid (Aib). Extensive studies of 
Aib peptides have shown the strong preference of this residue for 310/α-helix 
conformation.2.3-2.6, 2.8 Indeed, the most energetically favorable conformations for Aib 
residues almost invariably fall in the helical region of φ and ψ space (φ = ±60º, 
ψ = ±30º). The torsion angles at ααAA residues by which the local conformation is 
defined mainly depend on the size of ααAA side chains. Computional studies showed 








Deg    R = ethyl
Dpg    R = propyl  
 
Figure 2.1 Extended C-5 conformation in ααAAs. 
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dipropylglycine (Dpg), have significant energy minima in the fully extended (C-5) 
region of φ and ψ space (φ = ±180º, ψ = ±180º).2.9-2.10 In the derivative of Ac-xxx-NHMe 
(xxx = Deg, Dpg, Aib), the extended C-5 conformation is energetically favored over 
helical conformation in both Deg and Dpg derivatives (Figure 2.1).2.9-2.10 In contrast, the 
helical regions of φ and ψ space are pronounced energy minima for Aib residue. 
Interestingly, the conformational energy difference between the extended structure and 
the helical structure in both Deg and Dpg derivatives is often very small, which makes it 
possible for Deg and Dpg to adopt either helical or extended conformations. This 
characteristic property of the higher alkyl analogs of Aib has evoked particular interest 
in the study of their value as peptide secondary structure promoters. In this chapter we 
describe the synthesis and conformational analysis of short peptides with designed 
sequences stabilizing the fully extended conformation in the Dpg peptides. 
 In this work, a number of peptides containing natural α-amino acids and Dpg 
residues at alternating sequence positions were designed for conformational studies (Table 
2.1). In these peptide sequences, none of the L-amino acids had a strong preference for 
adopt helical conformation. Meanwhile the Dpg residues had some preference for 
extended region of  φ and ψ space. The incorporation of Dpg could significantly affect 
backbone constraints in these peptides and thus promote extended conformations. The 
purpose of preparation of these Dpg peptides is to examine the potential for β-strand 
aggregation through interstrand H-bonding and side-chain side-chain interactions. In 
both parallel and anti-parallel β-sheet, the pleating of the sheet is largely due to 
avoidance of steric interactions of the α-Hs inside the strand. If the α-Hs outside the 
 
 23 
Table 2.1 Primary sequences of Dpg and Nva peptides. 
Peptide     R1 R2 R3 R4    R5 R6 R7 R8 R9 
DPG-1 Ac-Lys Dpg Tyr Dpg Lys-NH2     
DPG-2 Ac-Glu Dpg Tyr Dpg Lys-NH2     
DPG-3 Ac-Glu Dpg Tyr Dpg Glu-NH2     
DPG-4 Ac-Lys Dpg Val Dpg      Thr Dpg Val Dpg Glu-NH2 
DPG-5 Ac-Glu Dpg Thr Dpg Lys-NH2     
NVA-2 Ac-Glu Nva Tyr Nva Lys-NH2     
NVA-5 Ac-Glu Nva Thr Nva Lys-NH2     
a Sequences are written from the N-terminus to the C-terminus. In all cases C terminus is 
  a primary amide (CO–NH2). 
 
 
strands are replaced with alkyl groups, in other words the natural amino acids at 
alternating positions are replaced with ααAAs, then it still allows hydrogen bonding 
from the inside edge, while blocking further hydrogen bonding formation from the 
opposite edge (Figure 2.2). In this study, the peptides containing Dpg residues were 
predicted to adopt extended conformation and interact with another strand to form a 
dimer in an anti-parallel β-sheet sheet pattern (Figure 2.3). In our design, the 
incorporation of lysine and glutamic acid residues at each ends of peptide DPG-2, DPG-
4, and DPG-5 was designed to probe the potential conformational effect resulting from 
residue-residue side-chain interactions (salt bridge). Peptides DPG-1 and DPG-3 where 
both ends of the sequence are either lysine or glutamic acid were designed as a 
comparison to DPG-2 to check for salt bridge formation. DPG-5 is an analogue of DPG-2, 
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difference. To further investigate ααAA’s impact on peptide backbone conformation, we 
prepared two peptide analogues NVA-2 and NVA-5, where Dpg residues are replaced by 
the α-amino acid L-norvaline. 
2.2 Results and Discussion 
 
2.2.1 Synthetic Approach to Nα-Protected ααAAs  
 
The synthesis of Να-Fmoc-Cα,α-dipropylglycine (Fmoc-Dpg-OH) and Να-Fmoc-
Cα,α-diisobutylglycine (Fmoc-Dibg-OH) started with formation of the hydantoins with 
Bucherer-Bergs procedure.2.11-2.12 A high yield of dipropyl-hydantoin was obtained from 
dipropyl ketone at room temperature, while the reaction with diisobutyl ketone needed to 
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          2.2a  79%
          2.2b  49%
          2.3a   68%
          2.3b   56%
a  R = CH2CH2CH3
b  R = CH2CH(CH3)2
 
Figure 2.4 Synthesis of Fmoc-Dpg-OH and Fmoc-Dibg-OH. 
 
time. Furthermore, hydrolysis of diisobutyl-hydantoin required harsher conditions than 
those for the dipropyl-hydantoin. Even under prolonged heating the hydrolysis of the 
sterically demanding diisobutyl-hydantoin was not completed (a significant amount of 
the hydantoin was recovered from reaction mixture). The ααAAs were isolated by 
lyophilizing the neutralized filtrate and extracting the resulting powder with 
ethanol/acetone mixture. A small amount of the amino acid was also recovered from 
extracting the precipitate formed during the neutralization process. The free ααAAs 
were Nα-protected to allow for solid-phase peptide synthesis. Protection of the amine 
with Fmoc-Cl using an in situ silylation procedure2.13 provided Fmoc-Dpg-OH and 
Fmoc-Dibg-OH in good yields. 
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2.2.2 Synthesis of Peptides Containing Dpg and Nva 
All peptides were prepared by solid-phase peptide synthesis using the Fmoc 
strategy.2.14 The natural amino acids, lysine, tyrosine, threonine, and glutamic acid were 
orthogonally protected and the side-chain protection were removed during cleavage. The 
Dpg component was introduced to the peptide via Nα-protected derivative, Fmoc-Dpg-
OH. The Fmoc-protected Dpg derivative has high solubility in DMF and can be readily 
employed in the automated synthesis system. Peptide bond formation with ααAAs is 
inherently problematic due to the steric hindrance at the tetrasubstituted α-carbon. 
Traditional activation methods, such as carbodiimide protocol, are usually inefficient for 
ααAA coupling, suffering from low yields, slow reaction rates, and a necessity for large 
excess of reagents.2.15 In the last two decades, a number of improved coupling reagents 
have been developed for efficient peptide assembly. Carpino et al. reported synthesis of 
peptides of difficult sequences with a phosphonium salt based on HOAt, called 7-
azobenzotriazolyoxytris(pyrrolidino)phosphonium hexafluorophosphate (PyAOP, see 
Chapter 1 for the structure).2.16 PyAOP has been successfully applied for the preparation 
of a range of peptides containing hindered amino acids, such as Aib. We therefore 
attempted the synthesis of Dpg peptides using PyAOP protocol. All peptides in this work 
were assembled on Perseptive Biosystem Peptide Synthesizer 9050 with Fmoc-PAL-
PEG-PS resin as the solid support. The coupling was performed in N, N-
dimethylformamide (DMF) using 4 equiv. of PyAOP, 8 equiv. of diisopropylethyl  
amine (DIEA), and 4 equiv. of amino acids (0.3 M). It was found that coupling onto N-  
termini of ααAAs could be greatly improved at elevated temperatures (Table 2.2). When  
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the synthesis of peptide DPG-1 with PyAOP protocol was carried out at room 
temperature, coupling at the C-terminus was straightforward. In contrast, the acylation of 
N-terminus of Dpg at room temperature turned out to be difficult (Table 2.2, entries 1, 
3). When the acylation was performed at 50 ºC, much improved yields were obtained 
(Table 2.2, entries 2, 4). These results were in line with the report that coupling at N- 
 
 
Table 2.2 Coupling of amino acids onto N-terminus of resin bound Dpg residue. 
Entry Coupling amino acid Activation method Time   

















  2 Fmoc-Tyr(OtBu)-OH PyAOP/DIEA/DMF   2  50 91 
  3 Fmoc-Lys(Boc)-OH PyAOP/DIEA/DMF   4  25 36 
  4 Fmoc-Lys(Boc)-OH PyAOP/DIEA/DMF   2  50 92 
a The coupling yield is determined by UV analysis of the Fmoc-deprotection.2.17 
 
 
terminus of a ααAA was more difficult than coupling at its C-terminus.2.18-2.19 Improved 
methods for efficient incorporation of sterically hindered ααAAs into peptide internal 
positions will be discussed in Chapter 4 of this dissertation.  
 After the last amino acid coupling, all peptides were acetylated with acetic 
anhydride in DMF. The crude peptides were cleaved from the resin by TFA and purified 
by reversed-phase HPLC on a C4 column. All peptides except DPG-3 were purified 
using a gradient of water and acetonitrile with 0.05% TFA in each solvent. Peptide 
DPG-3, which had the sequence Ac-Glu-Dpg-Tyr-Dpg-Glu-NH2, with no positively 
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charged side chains, was purified in more neutral condition with the presence of 
triethylammoniun acetate (TEAA) in each eluent (water and acetonitrile). All peptides 
were analyzed by analytical HPLC, amino acid analysis, and matrix-assisted laser 
desorption ionization mass spectrometry (MALDI). 
2.2.3 Conformational Studies by Circular Dichroism 
It was hypothesized that the Dpg peptides would adopt extended β-strand 
structure and might further associate to form β-sheets. The peptide with a β-sheet 
structure usually has a single minimum CD band between 210 and 225 nm and a relative 
strong positive band between 190 and 200 nm.2.20-2.22 The CD band intensities of β-
sheets are typically weaker than those of α-helices. Peptide conformations can be greatly 
affected by the presence of organic solvents like TFE and acetonitrile. To keep the CD 
analysis conditions comparable with biological environment, the conformational study 
of all Dpg peptides and NVA peptides was carried out in buffered aqueous solutions 
without any organic modifier.  
Peptides DPG-1, DPG-2, and DPG-3 have a similar sequence. The CD spectra of 
the three peptides are shown in Figure 2.5. All three peptides displayed similar, but 
characteristic CD bands in pH 7.0 phosphate buffer solution: a positive band near 
200 nm, a strong negative band at 185-190 nm, and a weak negative band at 230 nm.  
Peptide DPG-2 apparently exhibited larger CD intensities than DPG-1 and DPG-3 under 
the same conditions. The far UV band at 200 nm was likely an indication of either a β-
sheet or β-turn.2.23-2.26 The negative band near 230 nm could be indicative of either β-





































Figure 2.5 CD spectra of DPG-1, DPG-2, and DPG-3 in phosphate buffer. Conditions: 





































Figure 2.6 pH-Dependence of the CD spectra of DPG-2. Conditions: 100 µM peptide in 
10 mM of phosphate buffer at pH 7.0, 10 mM of acetate buffer at pH 5.0, and 10 mM of 


































Figure 2.7 Concentration-dependence of the CD spectra of DPG-2. Conditions: peptide 




































Figure 2.8 Temperature-dependence of the CD spectra of DPG-2. Conditions: 200 µM 

































Figure 2.9 Temperature-dependence of the CD spectra of DPG-5. Conditions: 250 µM 




































Figure 2.10 Temperature-dependence of the CD spectra of DPG-4. Conditions: 250 µM 




































Figure 2.11 CD spectra of NVA-2 and NVA-5 in phosphate buffer. Conditions: 250 µM 
peptide in 10 mM phosphate buffer, pH 7.0, 20 ºC. 
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Peptide conformational studies using CD mainly depends on analysis of the overall 
shape of CD spectra and comparison with standard peptide spectra. These CD spectra, 
which had negative band at 190 nm and 230 nm, positive band at 200 nm, were more 
likely from β-turn structures.2.25, 2.29 Peptide DPG-2 had lysine and glutamic acid at each 
end of the sequence and the oppositely charged side-chain might induce salt bridge in 
aqueous solution. The significantly larger ellipticity values for DPG-2 than those of 
DPG-1 and DPG-3 might stem from the strong H-bonding in DPG-2, which was 
stabilized by side chain interaction between lysine and glutamic acid. To examine this 
assumption, the CD measurement of DPG-2 was carried out in three buffer solutions 
with different pH values (Figure 2.6).  It was observed that DPG-2 possessed strong CD 
bands in neutral solution, and when the pH was decreased, there was a systematic 
reduction of ellipticity values for both positive and negative bands. This result indicated 
reduced secondary structures in low pH buffer solutions, where the carboxylate was 
converted to the acid form thus suppressing salt-bridge formation. The salt-bridge effect 
might explain why DPG-2 exhibited larger ellipticity values than DPG-1 and DPG-3, in 
which both termini contained either lysine or glutamic acid. In the concentration 
dependence study of DPG-2, which was carried out in phosphate buffer at pH 7 (Figure 
2.7), no conformational transition was observed in measured concentration range. The 
main CD bands were unchanged at various peptide concentrations, indicating a relatively 
stable secondary structure content in DPG-2. Temperature-dependence study of DPG-2 
also showed a stable secondary structure content as indicated by the nearly unchanged 
CD bands under measured temperatures (Figure 2.8). 
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 Peptide DPG-5 had the sequence homologous to DPG-2, except that tyrosine was 
replaced by threonine. Surprisingly, the CD spectra of DPG-5 displayed a different 
pattern from that of DPG-2 (Figure 2.9). There were a strong minimum at 198 nm and a 
weak minimum at 230 nm respectively, indicating that the peptide adopted both 
random coil and β-turn or β-sheet like structures.2.27, 2.30 Upon heating, the CD band 
intensity at 198 nm became weaker, while the intensity at 230 nm turned stronger. This 
kind of trend is usually an indication of increased content of peptide ordered 
structures.2.27 Peptide DPG-4 had a longer sequence than other peptides in this study. 
The CD spectra of DPG-4 looked very similar to those of DPG-5, with minima at 198 
and 228 nm respectively (Figure 2.10). Upon heating, the CD bands from DPG-4 
showed the same trend as DPG-5, indicating an increased content of β-turn or β-sheet 
and reduced content of random coil.  
 To study the effect of Dpg residues on short peptide conformational preference, 
we synthesized two pentapeptide analogues NVA-2 and NVA-5. Peptides NVA-2 and 
NVA-5 had the similar sequence as DPG-2 and DPG-5 respectively, except that each 
Dpg residue was replaced by its amino acid analogue L-norvaline (Cα-propylglycine). It 
was observed that both NVA-2 and NVA-5 mainly adopted random coil structure as 
indicated by the unique negative band at 197 nm (Figure 2.11). The pronounced 
difference between the CD spectra of Dpg peptides and Nva peptides indicated that 
incorporation of norvaline into short peptides didn’t induce ordered structures, while 
incorporation of Dpg residues could significantly affect conformational behavior of the 
short peptides. The CD spectrum of DPG-2 looked totally different from that of NVA-2, 
where substitution of Dpg residues with norvalines leads to almost total loss of ordered 
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structures. In contrast, DPG-5 and NVA-5 gave similar CD spectra, though the CD 
spectra of DPG-5 had a weak minimum at 230 nm. From the CD analysis of DPG-5, it 
seemed that this peptide contained mainly random coils and a small amount of β-turn or 
β-sheet like structures. NVA-5 adopted predominately order less structures that were 
indicated by the characteristic CD band. CD analysis of Dpg peptides and Nva peptides 
indicated that Dpg residues could impose considerable constraints on peptide backbone 
thus induce ordered structure, while the conformational impact of Dpg residues on 
peptide backbones was also influenced by other residues in the sequence, such as 
tyrosine and threonine. The CD analysis revealed some information about the Dpg 
peptide secondary structures, but the CD spectra of β-turns or β-sheets are more difficult 
to interpret than those of α-helical peptides. Further study is required for more accurate 
structure determination. In fact, these indicative data obtained from CD study will be 
employed to assist the peptide solution structural analysis by NMR spectroscopy. 
2.2.4 NMR Studies of the Solution Structure of Dpg Peptides 
Peptide DPG-2 and DPG-5, which exhibited characteristic CD spectrum features, 
were further analyzed by NMR. To keep the NMR study condition consistent with that 
in CD study, the peptide samples in NMR experiment were prepared in 90% aqueous 
phosphate buffer and 10% D2O. Figure 2.12 and Figure 2.13 show 1D 1H NMR 
spectrum of DPG-2 and DPG-5 respectively. The assignment of the 1D spectrum was 
made using peak integration, 2D Correlated Spectroscopy (COSY), Total Correlation 
Spectroscopy (TOCSY), Nuclear Overhauser and Exchange Spectroscopy (NOESY), 
Rotating Frame Overhauser Enhancement Spectroscopy (ROESY), Heteronuclear (1H-
































Figure 2.12 1H NMR of DPG-2. Conditions: 10 mM DPG-2 in 30 mM phosphate buffer 
































Figure 2.13 1H NMR of DPG-5. Conditions: 10 mM DPG-5 in 30 mM phosphate buffer 
at pH 7; Solvent composition, H2O-D2O (9:1); 300MHz. 
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Table 2.3 NMR parameters of peptide DPG-2 in phosphate buffer. 
Residue   NH 
(ppm) 
   α  
(ppm) 
       β 
   (ppm) 
 Others 
  (ppm) 
3JHNCαH 
   (Hz) 
Glu(1) 8.57 4.05 1.93, 2.02 γ  2.30     4.9 
Dpg(2) 8.18    - 1.45, 1.55 γ  0.73, 1.05 
δ  0.74, 0.82 
 
     - 
Tyr(3) 7.69 4.48 2.80, 3.15 δ  7.12 
ε  6.81 
 
    7.1 
Dpg(4) 7.79    - 1.81, 1.91 γ  1.15, 1.08 
δ  0.94, 0.96 
 
     - 
Lys(5) 8.04 4.22 1.80, 1.90 γ  1.45 
δ  1.70 
ε  3.05 
    7.1 
 
 
Table 2.4 NMR parameters of peptide DPG-5 in phosphate buffer. 
Residue NH 
(ppm) 
   α 
(ppm) 
       β 




   (Hz) 
Glu(1) 8.39 4.22 1.95, 2.05 γ  2.30     5.7 
Dpg(2) 8.29    - 1.75, 1.83 γ  1.15, 1.13 
δ  0.88, 0.90 
 
     - 
Thr(3) 7.72 4.24 4.23 γ  1.21 
 
    7.7 
Dpg(4) 7.86    - 1.86, 1.93 γ  1.16, 1.19 
δ  0.89, 0.90 
 
     - 
Lys(5) 7.85 4.24 1.82, 1.90 γ  1.46 
δ  1.69 
ε  2.98 














Figure 2.14 Amide-amide region of ROESY spectrum of DPG-2. The NOE data were 














Figure 2.15 Amide-α-hydrogen region of ROESY spectrum of DPG-2. The NOE data 












































Figure 2.16 NOE connectivities on the backbone of DPG-2. The NOE data were 
obtained from a 400 MHz NMR using a 10 mM sample in phosphate buffer. Strong 













Figure 2.17 Amide-amide region of ROESY spectrum of DPG-5. The NOE data were 














Figure 2.18 Amide-α-hydrogen region of ROESY spectrum of DPG-5. The NOE data 

















Figure 2.19 1H NMR of amide NH in DPG-2 at various temperatures. Conditions: 10 
mM peptide in 30 mM phosphate buffer; 500 MHz.
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In the sequential assignment procedure, spin systems of common L-amino acids like 
tyrosine and lysine were first assigned based on COSY, TOCSY, and peak integrations. 
Connectivities between the 1H spin system of sequentially neighboring monomeric units 
were established by heteronuclear COSY and NOEs. The resulting segments of 
neighboring 1H spin systems were then matched against the corresponding segments in 
the sequence of the peptide chain to obtain sequence-specific assignments.  The relevant 
chemical shifts of protons in DPG-2 and DPG-5, and coupling constants 3JHNCαH are 
summarized in Table 2.3 and Table 2.4 respectively. Inspection of the chemical shifts 
revealed that all three Cα protons on the backbone of DPG-2 were well separated, while 
the three Cα protons in DPG-5 were positioned very close to each other. The NMR input 
for peptide secondary structure analysis depends primarily on the 1H-1H NOE 
measurements which detect the interproton distance of 5Å or less. In the proposed β-sheet 
structure illustrated in Figure 2.3, the interstrand distance of several pairs of protons, such 
as dNN(Dpg2, Dpg4) and dαN(Lys5, Dpg2) would be relatively short and should be detected 
by NOE measurements. Figure 2.14 and Figure 2.15 illustrated the extended ROESY of 
amide-amide region and amide-α-hydrogen region of DPG-2. The cross peaks that were 
characteristic of the proposed β-sheet structure were not observed. Instead, there were a 
number of sequential NOEs in the spectra, which were usually displayed by helical 
structures. The NOE connectivities on DPG-2 backbone were indicated in Figure 
2.16. Besides the sequential NOEs, there were some interesting NOE interactions 
between protons on certain residue side-chains, such as tyrosine aromatic protons 
and Dpg (2) γ and δ protons. This kind of interaction might stem from a folded structure 
that caused the side-chains on adjacent residues to be close to one another.   The finger 
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print regions of ROESY of DPG-5 were displayed in Figure 2.17 and Figure 2.18 
respectively. There were a number of sequential NOEs in amide-amide region. However, 
currently it is impossible to assign the amide-α-Hs for DPG-5 due to overlapped peaks of 
α-H of lysine, threonine, glutamic acid, and β-H of threonine. The unavailable 
assignments of the individual amide-α-H cross peak makes NOE information needed for 
DPG-5 structure determination insufficient. 
 Dyson and Wright reported several NMR criteria for characterizing peptides with 
β-turn populations.2.32 These criteria include depressed temperature coefficients of H-
bonded amide protons and characteristic NOE connectivities, such as dNN(i, i + 1)  
 
Table 2.5 Temperature coefficient of residues in DPG-2.a 
DPG-2 Residue  Obsd. Temp. Coefficient  
       (ppm/K × 103) 
Reported Temp. Coefficient 
        (ppm/K × 103)b 
Glu                -7.0                   -6.0 
Dpg(2)                -7.7                     - 
Tyr                -5.5                    -8.0 
Dpg(4)                -3.4                      - 
Lys                -8.3                    -7.2 
NH(6)(upfield)                -6.1                      - 
NH(6)(downfield)                -5.6                      - 
a The calculation was carried out using the NH chemical shift data obtained 
  between 278-313K.  
b The peptides adopted random coil under measured conditions.2.33 
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between residue 3 and 4 of the turn and dαN(2, 3), dαN(2, 4) NOE 
connectivities. Temperature coefficients represent the relative change rate of NH 
chemical shift over a range of measured temperature.  The temperature 
coefficients for residues in DPG-2 were calculated using the data obtained between 
278K and 313K (Figure 2.19; Table 2.5). The depressed temperature coefficient 
indicates that the amide proton is protected from exchange to some degree. In the 
ROESY spectrum of DPG-2, the observed crosspeaks dαΝ(Glu1, Dpg2) (Figure 2.15) 
and dNN(Dpg2, Tyr3) (Figure 2.14) indicates a type II β-turn structure with an 
intramolecular H-bond between the acetyl carbonyl oxygen and the tyrosine NH. The 
temperature coefficient of Tyr NH was substantially smaller than the reported value 
from tyrosine in random coils,2.33 indicating that tyrosine NH in DPG-2 might be 
involved in H-bonding. The dNN(Tyr3, Dpg4) crosspeak and depressed temperature 
coefficient of the Dpg4 NH suggested another β-turn in residue Glu1-Dpg4. Though 
there are no reported temperature coefficients for Dpg residues, the pronounced 
difference between Dpg (2) and Dpg (4) NH temperature coefficients suggested that 
the NH of Dpg4 is H-bonded. Based on the NMR data and CD results, a backbone 
conformation consists of consecutive β-turn structure, namely a type II-β turn from the 
acetyl group to Tyr3 and a type I’ β-turn from Glu1 to Dpg4, was generated and refined 
by energy minimization program using SYBYL.2.34 This computer generated solution 
structure of DPG-2 was consistent with NMR data (Figure 2.20). The H-bonds are 
indicated by dotted lines. In the model the aromatic ring of tyrosine and the prochiral 
(S) side chain of Dpg2 were on the same side of the turn and they were close to each 








Figure 2.20 Minimized molecular model of populated folded structure of DPG-2  
in aqueous solution. Hydrogen bonds are indicated by doted lines. 
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connectivities. Also, the side chains of glutamic acid and lysine are close in space, 
consistent with a salt bridge interaction that further stabilizes the β-turn structure in 
DPG-2, as shown in the pH-dependence CD of DPG-2. The consecutive β-turn structure 
observed in DPG-2 was a short section of a left-handed 310-helix which was 
characterized by short sequential and medium range NH NOE connectivities.  
 Dpg residues could adopt both extended and helical conformation, depending on 
peptide sequence, length, and environmental factors.2.35 It has been reported that Dpg 
residues are likely to adopt C5 conformation in the sequence where flanking residues 
have a strong tendency to adopt extended structures. Meanwhile, in helix-promoting 
situation, Dpg could be easily accommodated into a helical conformation2.33 
Indeed the conformation energy of extended and helical structure in Dpg 
derivatives were often close to each other, subtle sequence modification could affect the 
peptide conformational preference. 
2.3 Conclusions 
Cα,α-disubstituted amino acids have been recognized as a means of introducing 
backbone conformation constraints in peptides. In this work, several peptides containing 
Dpg and its analogous, L-norvaline, were synthesized for conformational studies. It was 
found that at elevated temperatures PyAOP was a powerful coupling reagent for 
incorporating Dpg residues into peptide internal positions. Systematic structural studies 
on Dpg peptides were performed by CD and NMR techniques. All Dpg peptides 
displayed certain content of order secondary structures, while the Nva peptides adopted 
mainly random coils.  It was observed that in peptide DPG-2, Ac-Lys-Dpg-Tyr-Dpg-
Glu-NH2, Dpg residues adopted helical structures, instead of extended structures.  It was 
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interesting to note the conformational difference between DPG-2 and DPG-5 where 
substitution of the central residue substantially changed the conformational preference of 
the peptide.  Though Dpg residues could impose considerable constraints on peptide 
backbone, the conformation of the Dpg peptides was affected by the whole sequence, not 
just a single residue.  In fact, the local structural behavior of Dpg residues was context 
dependent. Dpg residues were likely to adopt helical conformation in a helix-promoting 
sequence, while they tended to adopt extended C5 structures in a sequence where the 
residues had a strong preference to extended conformation. It seemed that tyrosine was 
likely to adopt left-handed helical conformation and thus could be easily fitted into a 
type I’ β-turn structure, while threonine which had a branched side chain didn’t favor 
helical structures in the present sequence context. The results bore this out in that DPG-2 
possessed consecutive β-turns, while DPG-5 mainly adopted random coil structure. It 
was also observed in this study that side chain interactions between oppositely charged 
groups could strengthen the intramolecular H-bonding and consequently stabilize the 
Dpg peptide secondary structures. In our recent study of conformational behavior of 
NVA-2, a peptide analogue of DPG-2, the peptide showed a strong tendency to 
polymerization in a neutral phosphate buffer even under diluted concentrations (~200 
µM). This result may indicate a β-sheet formation in NVA-2 resulting from cross-strand 
H-bonding as predicated for DPG-2. If NVA-2 had the proposed aggregation in aqueous 
solution, structural studies could reveal the impact of norvaline and dipropylglycine on 
peptide conformation preference, which in turn will facilitate the design of β-strand 
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a  R = CH2CH2CH3
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A solution of 4-heptanone (5.0 g, 43.8 mmol), potassium cyanide (6.0 g, 91.9 
mmol), and ammonium carbonate (9.3 g, 96.3 mmol) in methanol (25 mL) and water (25 
mL) was heated at 50 ºC in a capped vessel for 36 hours. The precipitated solid was 
filtered and washed with small portion of water and dried in air. The hydantoin was 
obtained as off-white powder (6.6 g, 82%). 1H (250 MHz, CD3SOCD3) δ: 10.52 (s, 1H), 





The hydantoin 2.1a (2.5 g, 13.6 mmol) were suspended in 5 N NaOH (27.2 mL,  
136.0 mmol) and heated under reflux for 40 hours. The mixture was cooled, acidified to 
pH 6.5 with concentrated hydrochloric acid and filtered. The filtrate was dried by 
removal of the solvent under vacuo and washed with small portion of acetone to remove 
the unreacted hydantoin. Both the filtrate residue and the solid which precipitated out 
upon acidification were extracted with warm ethanol for several times. Pure white 
dipropyl glycine was obtained by removal of ethanol under vacuum condition (1.7 g, 
78%).  1H ( 250 MHz, CD3SOCD3) δ: 7.34(s, 2H), 1.55-1.10 (m, 8H), 0.88-0.78 (t, 6H). 
Να-(9-Fluorenylmethoxycarbonyl)-2,2-dipropylglycine (2.3a) 
To a solution of 2.2a (5 g, 31.4 mmol) in dry DCM (75 mL), trimethylsilyl 
chloride (7.9 mL, 62.8 mmol) was added in one portion and the mixture was heated 
under reflux for 6 hours. The mixture was cooled in an ice bath, then N,N-
diisopropylethyl amine (9.8 mL, 56.5 mmol) and Fmoc chloride (7.5g, 28.9 mmol) were 
added. The solution was stirred with cooling for 30 minutes and then warmed to room 
temperature. After stirring overnight, the mixture was concentrated under reduced 
pressure, the residue taken up in 2.5 % aqueous NaHCO3 (220 mL), washed with ethyl 
ether (2 x 120 mL). The ether layers were back washed with 2.5% aqueous NaHCO3 
(100 mL) and the combined aqueous layers were acidified by 1N HCl to pH 2.0 in the 
presence of ethyl acetate (170 mL). After separation, the aqueous layer was again 
extracted with ethyl acetate (2 x 100 mL). The combined organic layers were dried over 
MgSO4 and concentrated under reduced pressure, giving white solid product 2.3a (7.5 g, 
68%). 1H (250 MHz, CD3SOCD3) δ: 10.68 (s, 1H), 7.91-7.88 (d, 2H), 7.71-7.69 (d, 2H), 
 57 
7.44-7.29 (m, 4H), 6.95 (s, 1H), 4.28-4.21 (m, 3H), 1.76-1.74 (m, 4H), 1.20-1.10 (m, 
2H), 0.86-0.82 (m, 6H). Anal. Calcd for C23H27NO4 (381.45): C, 74.42; H, 7.13; N, 3.67. 
Found: C, 72.58; H, 7.13; N, 3.80. 
2,6-Dimethyl heptane-4-spiro-5’-hydantoin (2.1b) 
By using the similar procedure described for 2.1a, the mixture was heated under 
reflux for 60 hours and the resultant white precipitate was isolated by filtration and 
washed with small portions of water. Yield: 45%.  1H (250 MHz, CD3SOCD3) δ: 10.60 
(s, 1H), 7.85 (s, 1H), 1.63-1.38 (m, 6H), 0.88-0.78 (m, 12H). 
2,2-Diisobutylglycine (2.2b) 
The hydantoin 2.1b (2.0 g, 9.4 mmol) was suspended in 6 N KOH (19 mL, 113.0 
mmol) in a pressure-proof vessel and heated at 175 ºC and under 15 psi for 48 hours. By 
using the same work up procedure described for 1a, diisobutyl glycine was obtained as 
white solid (0.85 g, 50%).  1H (250 MHz, CD3SOCD3) δ: 6.67 (s, 2H), 1.80-1.36 (m, 
6H), 0.87-0.76 (m, 12H).  
Να-(9-Fluorenylmethoxycarbonyl)-2,2-diisobutylglycine (2.3b) 
Compound 2.3b was prepared using the same procedure described for 2.3a. 
Yield, 56%.  1H (250 MHz, CD3SOCD3) δ: 13.25 (s, 1H), 7.90-7.87 (d, 2H), 7.70-7.68 
(d, 2H), 7.44-7.34 (m, 4H), 6.49 (s, 1H), 4.32-4.31 (m, 3H), 2.03-1.98 (m, 2H), 1.60-
1.47 (m, 4H), 0.81-0.78 (m, 12H). Anal. Calcd for C25H31NO4 (409.50): C, 73.32; H, 
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Ac-Glu-Dpg-Tyr-Dpg-Lys-NH2   
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Figure 2.22 Assembly of peptide DPG-2. 
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All peptides synthesis was carried out on PerSeptive Biosystem 9050 synthesizer 
using Fmoc-PAL-PEG-PS resin as illustrated in the synthesis scheme for DPG-2. The 
Fmoc group was removed by 1,8-diazabicyclo[4.5.0]undec-ene (DBU)-piperidine-DMF 
(2:20:80) solution and the excess amino acids (4 equiv.), PyAOP(4 equiv.), and DIEA(8 
equiv.) were employed in the coupling process. To enhance the coupling with ααAAs, a 
water jacket was utilized to keep the column at 50 ºC. The acetylation of the peptide N 
terminus was performed by manual synthesis. The peptide bound to resin was treated 
with excess 0.2 M of Ac2O in 0.28 M of DIEA/DMF solution (16 equiv.) for 2 hours. 
After rinsing with DMF and DCM and drying under high vacuum for 4 hours, the resin 
was treated with standard cleavage solution (trifluoroacetic acid-triisopropylsilane-
water: phenol, 8.8:0.2:0.5:0.5) to cleave the peptide from the resin. The resulting 
solution was diluted with cold 40% acetic acid solution, washed with cold diethyl ether 
(5 x 40 mL), and lyophilized to yield to crude peptides. 
2.4.3 Peptide Purification and Characterization 
The crude peptides were purified by reverse phase HPLC using Waters Deltapak 
C4 column (15 µm, 300 A, 25 x 100mm). The flow rate was 1 mL/Min for analytical 
HPLC and 10 mL/min for preparative HPLC. For all peptides except peptide DPG-3, 
solvent A was 0.05% TFA in water, solvent B was 0.05% TFA in acetonitrile. For 
peptide DPG-3, solvent C and D was utilized for purification. Solvent C was 0.025M 
TEAA in water, and solvent D was 0.025M TEAA in acetontrile/water (90:10) solution. 
The identity and purity of the peptides was confirmed by quantitative amino acid 
analysis and matrix-assisted laser desorption/ionization mass spectrometry. 
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Peptide DPG-1 (C39H68N6O6) 
Preparative HPLC purification was carried out using a linear gradient from 5% to 
50% B over 50 minutes, tR = 24.5 min., overall yield 55%; MALDI (M + H)+ m/z calcd 
762.0, obsd 761.9. 
Peptide DPG-2 (C38H63N6O8) 
Preparative HPLC purification was carried out using a linear gradient from 5% to 
50% B over 60 minutes, tR = 26.7 min., overall yield 46%; MALDI (M + H)+ m/z calcd 
761.9, obsd 761.9. 
Peptide DPG-3 (C37H58N6O10) 
Preparative HPLC purification was carried out using a linear gradient from 5% to 
60% C over 60 minutes, tR = 25.7 min., overall yield 47%; MALDI (M-H)- m/z calcd 
761.9, obsd 761.8. 
Peptide DPG-4 (C57H106N10O12) 
Preparative HPLC purification was carried out using a linear gradient from 10% 
to 80% B over 65 minutes, tR = 38.7 min., overall yield 18%; MALDI (M + H)+ m/z 
calcd 1181.5, obsd 1181.5. 
Peptide DPG-5 (C33H61N6O9) 
Preparative HPLC purification was carried out using a linear gradient from 5% to 
50% B over 50 minutes, tR = 27.3 min., overall yield 35%; MALDI (M + H)+ m/z calcd 





Peptide NVA-2 (C38H51N6O8) 
Preparative HPLC purification was carried out using a linear gradient from 5% to 
50% B over 50 minutes, tR = 24.9 min., overall yield 58%; yield 58%; MALDI (M + H)+ 
m/z calcd 720.8, obsd 720.8. 
Peptide NVA-5 (C33H49N6O9) 
Preparative HPLC purification was carried out using a linear gradient from 5% to 
50% B over 50 minutes, tR = 25.0 min., overall yield 55%; MALDI (M + H)+ m/z calcd 
674.7, obsd 674.8. 
2.4.4 Circular Dichroism 
Circular dichroism measurements were performed on a (+)-camphor sulfonic 
acid calibrated Aviv 60DS spectrophotometer. The samples were prepared as stock 
solutions in buffer and diluted to the desired concentration in proper solution for 
measurements. The CD measurements were recorded over a 250-180 nm range using a 
quartz cell of 1 mm path length, 1 nm bandwidth, 20 nm/min scan speed, and a time 
constant of 0.5 s. Molar ellipticity was calculated using the formula [θ] = 
[θ]obs(MRW/10cd), where [θ]obs was the mean residue molecular weight of the peptide 
(molecular weight divided by the number of peptide bonds), c was the concentration of 
the sample in mg/mL, and d was the optical pathlengh of the cell in cm. All spectra were 
corrected for buffer (or solvent) contributions and presented in unit of molar ellipticity. 
2.4.5 Nuclear Magnetic Resonance 
The NMR studies of Peptide DPG-2 and DPG-5 were performed on Bruker 
ARV-300, Avanee 400, and AM-500 NMR spectrometers. The samples contained 11.5 
mM peptide in 30 mM phosphate buffer, 90:10 H2O/D2O. All spectra of peptides were 
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referred to sodium 3-(trimethylsiyl)propionate-2, 2, 3, 3-d4 (TSP). The 3JNα values were 
determined from the amide signals in the 1D spectra over the temperature range of 278-
318 K (every 5 K). These 3JNα values didn’t vary significantly with temperature. The 
2-D scalar COSY, TOCSY, ROESY experiments were run in phase-sensitive mode 
using quadrature detection by time-proportional phase incrementation of initial pulse. 
TOCSY experiment was carried out using a mixing time of 80 ms, and a mixing time of 
200 ms was employed for ROESY experiment. Amide exchange experiments were 
repeated twice, and the average results were reported. Plots of temperature (278-318 K) 
vs peak position (ppm) for each of the amide protons were made for temperature 
coefficient determination. 
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SYNTHESIS OF STERICALLY HINDERED Cα,α-DISUBSTITUTED AMINO 
ACIDS FROM NITROACETATE* 
 
3.1 Introduction 
The discovery of Cα,α-disubstituted amino acids (ααAA, Figure 3.1) in 
biological systems and their propensity to induce secondary structure has resulted in an 
increased interest in de novo peptide design containing ααAAs.3.1-3.6 The prototype of 
ααAA, α-aminoisobutyric acid (Aib), is a naturally occurring amino acid observed in a 
number of antibiotic peptides, such as alamethicin, tricorzianine, emerimicin, and 






Aib      R = CH3      
Dpg     R = CH2CH2CH3 
Dbzg   R = CH2Ph  
 
Figure 3.1 Structure of representative ααAAs. 
 
 
*Reprinted in part with permission from The Journal of Organic Chemistry, 2001, 
Volume 66, pages 7118-7124; Fu, Y.; Hammarström, L. G. J.; Miller, T. J.; Fronczek, F. 
R.; McLaughlin, M. L.; Hammer, R. P., Sterically Hindered Cα,α-Disubstituted α-Amino 
Acids: Synthesis form α-Nitroacetate and Incorporation Into Peptides. Copyright 2001 
American Chemical Society. 
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sequences. Extensive conformational studies of both natural and synthetic Aib peptides 
have established the strong preference of this residue for 310/α-helical sructure.3.11-3.16 
Higher alkyl analogous of Aib, such as Cα,α-dipropylglycine (Dpg), favor 
extended structure, especially in the homo-sequence peptides.3.17-3.20 Meanwhile, more 
sterically hindered ααAAs, such as Cα,α-dibenzyl glycine (Dbzg), have shown a 
overwhelming preference to the extended C5 conformation.3.21-3.22 Unlike Aib, sterically 
demanding ααAAs have not been commonly used in peptide design.  This is mainly due  
 
 






























to the difficulty in ααAA preparation and in peptide assembly containing hindered 
ααAAs. The most common methods of ααAA synthesis include the Strecker and 
Bucherer-Bergs method (Figure 3.2).3.23-3.24 In Strecker method, amino acid is prepared 
from hydrolysis of amino nitrile which is obtained by reacting ketone with ammonium 
salt and cyanide. The Bucherer-Berg synthesis is characterized by formation of a 
hydantoin, which is subquently cleaved under basic condition to yield the free ααAA 
We have found the Bucherer-Berg method convenient and effective for preparation of a 
number of hydantoins that can be hydrolyzed to ααAAs. Also we and others have 
developed milder methods for cleaving hydantoins which are functionalized by t-
butyloxycarbonyl groups.3.25-3.26 However, several more sterically hindered hydantoins, 
including dibenzyl hydantoin (R = Bn), have been impossible to hydrolyze to the free 
amino acids, even under the most extreme condition. For example, hydrolysis of 
dibenzyl hydantoin with either strong base (6 M KOH, 20 psi, 180 ºC, 2 days) or strong 
acid (10 N HBr, reflux, 2 days) gave staring material as the only isolable product. Also, 
it has been found that the Bucherer-Bergs route cannot be extended to a number of 
noncyclic difunctionalizedketones, such as 1,3-dihydroxy 2-propanone, 4-
oxoheptanedinitrile, and 1,5-diamino-3-pentanone, due to their resistance to hydantoin 
formation.3.27 These and other limitation of the hydantoin approach have led to the 
development of alternative synthesis of ααAAs, including glycine anion and cation 
equivalents.3.28-3.30  
 Nitroacetate esters have long been recognized as potentially usefully synthetic 
intermediate for the preparation of amino acids as well as other biologically significant  
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compounds, such as amino alcohols, nitro amines, and carbohydrate derivatives, etc.3.31 
In nitroacetate esters, the presence of the active methylene group makes these esters 
unique intermediates for the formation of carbon-carbon bonds. Alkylation of 
nitroacetate esters have usually resulted in racemic monoalkylations, and the 
predominant products were often results of C-and/or O-alkylation.3.31-3.35 Figure 3.3 
shows the equilibrium of the anions of nitroacetate ester. The previously reported C-



















the reaction tool a prolonged time.3.36 Electrochemically generated anions have also been 
used on a small scale to perform mono- and dialkylations of nitroacetate esters.3.37 In this 
study we report an efficient route for preparation of sterically hindered ααAAs via 
alkylation of nitroacetate. The strategy and conditions proposed herein employ the 
commercially available ethyl nitroacetate 3 along with 2 equiv each of a tertiary amine 
base and an electrophile to provide a variety of novel Cα,α-dialky nitroacetate esters 
(Figure 3.4). Furthermore, methods for preparing Nα-Fmoc-protected ααAAs, including 


















3.3 3.4  
 
Figure 3.4 Dialkylation of ethyl nitroacetate. 
 
3.2 Results and Discussion 
We have found that treatment of ethyl nitroacetate with 2 equiv of DIEA in the 
presence of catalytic amounts of tetralkylammonium salts, followed by the addition of an 
activated alkyl halide or Michael acceptor, gave the disubstituted nitroacetate ester in 
good to excellent yields (Table 3.1). A number of bases have been tried for the 
deprotonation, where DIEA gave the best result. DIEA was employed based on evidence 
which suggests that ethyl nitroacetate anion exhibits high nucleophilic reactivity in the 
presence of a quaternary ammonium cation that does not tend to form a strong ion 
pair.3.37 The reactivity of the anion was further increased when a catalytic amount of 
tetraalkylammonium salt was added to the reaction. The benzyl bromides gave rapid 
conversion to dialkylated products 3.4 in a matter of minutes to hours. Reactions were 
initially exothermic-benzyl bromides having electron-withdrawing substituents (Table 
3.1, entries 2-4) needed to be cooled initially to control the reaction. When the reaction 
was finished, a large mount of diethyl ether was added to the reaction mixture to 
precipitate out the ammonium salt formed between DIEA and HBr.  Unlike benzyl  
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Table 3.1 Alkylation of ethyl nitroacetate to Cα,α-dialkylated nitroacetate. 
 
Entry Electrophile Time (h) Temp (ºC) Prod. No. Yield %a 
 





    1 
 
     25-60b 
 
    3.4a 
 
   63 
    2 p-O2NPhCH2Br 
 
    2      0-25     3.4b    75 
    3 p-NCPhCH2Br 
 
    2      0-25     3.4c    82 
    4 p-CH3O2CPhCH2Br 
 
    2      0-25     3.4d    72 
    5 (CH3)3CO2CCH2Br    24       50     3.4e    79 
    6 CH2=CHCH2Br 
 
   24       60     3.4f    tracec 
    7 CH2=CHCH2I     24       60     3.4f    45 
    8 CH2=CHSO2Ph    30       25     3.4g    70 
    9 CH2=CHCO2t-Bu    48       25     3.4h    89 
   10 CH2=CHCN    48       25     3.4i    87 
a All percentage yields refer to isolated, analytically pure products. 
b Spontaneous exotherm to 60 °C. 
c Major product is monoallylated product, ethyl 2-nitro-4-pentenoate. 
 
bromides, dialkylation with tert-butyl 2-bromoacetate (Table 3.1, entry 5) required 
longer reaction time at slightly elevated temperature (50 ºC) to provide 3.4e in 79% 
yield. Allyl bromide gave only trace amounts of the diallylated product, ethyl 2,2-
bis(allyl)-2-nitroacetate (3.4f), even after prolonged reaction times and heating. The 
major product of this reaction was the mono-C-allylated derivative, ethyl 2-nitro-4-
pentenoate (65%). In order to improve the yield, allyl iodide was tried as the electrophile 
for the dialkylation under different reaction conditions, including in several different 
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solvents (THF, DMF, and MeCN), and in the presence of different catalysts, including 
tetrabutylammonium bromide and tetraethylammonium bromide, and 
tetrabutylammonium iodide. It was observed that allyl iodide in DMF with the presence 
of tetrabutylammonium iodide gave highest yield (45%), however, the product was still 
admixed with monoallylated ester. In this study, a number of activated alkenes, 
including phenyl vinyl sulfone, tert-butyl acrylate, and acrylonitrile, were employed for 
the double Michael-type addition to ethyl nitroacetate.3.27 These reactions were carried 
out in MeCN at room temperature and gave the tetrafunctional nitroesters in good yields 
(Table 3.1, entries 8-10). 
 The high yields for these dialkylation reactions make this a particularly viable 
route to symmetrically substituted ααAAs (vide infra) with or without side chain 
functionality. As examples of the utility of these α-amino acid precursors, the dibenzyl 
derivative 3.4a and di-tert-butyl acetate derivative 3.4e were converted to Nα-
fluorenylmethyloxycarbonyl (Fmoc)-protected Cα,α-dibenzylglycine (Dbzg) 3.7a and 
2,2-bis(tert-butylcarboxymethyl)glycine (Bcmg(OtBu)2-OH) 3.7e,3.27 respectively 
(Figure 3.5). First, several methods were investigated for reduction of the nitro group to 
an amino group. Nitro ester 3.4a was readily reduced with Zn/acetic acid to afford the 
amino ester 3.5a in high yield (Table 3.2, entry 1). Results for catalytic hydrogenation 
approaches to reduce the nitro group were mixed. Reduction of the nitro group of Cα,α-
disubstituted nitro triester 3.4h, an analogue of 3.4e, with hydrogen (50 psi) over T-1 
Raney Ni afforded the desired amino triester 3.5h in excellent yield (Table 3.2, entry 4). 
















































a   R = CH2Ph
e   R = CH2CO2tBu




Figure 3.5 Synthesis of Nα-Fmoc-protected sterically hindered ααAAs. 
 
ammonium formate in presence of Pd resulted in almost quantitative conversion of 3.4h 
to the corresponding hydroxylamine 3.6h (Table 3.2, entries 5 and 6). Similarly catalytic 
transfer hydrogenation of 3.4a also produced the hydroxylamine product 3.6a (data not 
shown). It has been suggested that Pd catalysis is preferable for partial reduction of 
aliphatic nitro groups to hydroxylamines.3.38-3.39 Boger et al. reported hydrogenation of 
tertiary aliphatic nitro groups over a variety of catalysts.3.40 They found that 
hydrogenation over Raney Ni provided the amino derivatives with variable amounts of  
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Table 3.2 Reduction of Cα,α-disubstituted nitro esters. 
 
Entry Nitro ester  Conditionsa Product Yield %b 
   1     3.4a Zn/AcOH    3.5a   81 
   2     3.4e H2/Raney Ni    3.5e   92 
   3     3.4h H2/Raney Ni    3.5h   92 
   4     3.4h H2/10% Pd-C    3.6h   97 
   5     3.4h HCO2NH4,10% Pd-C    3.6h   97 
aHydrogenation over Pd or Ni were carried out in hydrogenation flask at 50 psi; 
 Reduction with Zn/AcOH or HCO2NH4 in the presence of Pd-C was performed in a 
 regular round bottom flask. 
bAll yields refer to isolated pure products. 
 
corresponding hydrocarbon from loss of the nitro group, while reduction using H2-Pd/C, 
HCO2NH4-Pd/C, and H2-PtO2 afforded mixtures including the hydroxylamine and 
hydrocarbon. The observed partial reduction of Cα.α-disubstituted nitro ester 3.4h into 
the hydroxylamine ester may be attributed to the relatively low activity of Pd catalysts 
and the intramolecular hydrogen bonding which enhanced the stability of the 













Figure 3.6 Intramolecular hydrogen bonding in hydroxylamine. 
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reduction of nitro triester 3.4e was carried out using H2/Ni at 50 psi, and the desired 
amino ester 3.5e was obtained as a clear crystalline crystalline solid in excellent yield 
(Table 3.2, entry 3).3.27  
 To make the desired Fmoc-protected amino acids, the ester of the α-carboxylate 
must first be removed. For amino ester 3.5a this was readily accomplished by 
saponfication under strong basic conditions (2M KOH) in refluxing H2O-EtOH (v/v, 
2:1) to give the free ααAA 3.1a in 88% yield (Figure 3.5). Unlike saponfication of 3.5a, 
hydrolysis of the ethyl ester of triester 3.5e required more precise conditions to avoid 
concurrent tert-butyl ester hydrolysis. Selective hydrolysis was realized by treatment of 
3.5e with 3 equiv of lithium hydroxide in H2O-EtOH (v/v, 1:2) at 50 ºC to give the side –
chain protected ααAA 3.1e in 82% yield.3.27 Acid-catalyzed hydrolysis of 3.5e with 
HCl, nucleophilic dealkylation, and saponfication using KOH failed to selectively 
hydrolyze the ethyl ester. The low selectivity of ethyl vs tert-butyl ester hydrolysis in 
this compound is most likely due to the steric congestion of the ethyl ester resulting form 
its proximity to the quaternary α-carbon. The free ααAAs are Nα-protected to allow for 
solid-phase peptide synthesis. Protection of the amine with Fmoc-Cl using an in situ 
silylation procedure3.41 provided Nα-(9-Fluorenylmethoxycarbonyl)-2,2-dibenzylglycine 
(Fmoc-Dbzg-OH, 3.7a) in 80 % yield and Nα-(9-Fluorenylmethoxycarbonyl)-2,2-
bis(tert-butyl-carboxymethyl)glycine (Fmoc-Bcmg(OtBu)2-OH, 3.7e) in 71% yield. The 
synthetic route allows facile synthesis of sterically hindered ααAAs, even those with 





In this study, we have presented a new strategy for preparation of sterically 
hindered ααAAs via mild dialkylation of nitroacetate. The method has been shown to be 
successful for the synthesis of highly sterically encumbered ααAAs (Fmoc-Dbzg-OH), 
as well as the synthesis of chemically sensitive ααAAs, such as the Να- and side chain-
protected tetrafunctional derivatives (Fmoc-Bcmg(OtBu)2-OH). Both ααAAs can be 
directly used in solid-phase peptide synthesis. This methodology should prove 
invaluable for the preparation of previously unavailable ααAAs with and without side 
chain functionality.  
3.4 Experimental 

















3.3 3.4a  R = CH2Ph
3.4b  R = p-CH2PhNO2
3.4c  R = p-CH2PhCN
3.4d  R = p-CH2PhCO2CH3
3.4e  R = CH2CO2C(CH3)3
3.4f   R = CH2CH=CH2
3.4g  R = CH2CH2SO2Ph
3.4h  R = CH2CH2CO2C(CH3)3
3.4i   R = CH2CH2CN  
 
Figure 3.7 Synthesis of dialkylated ethyl nitroacetate. 
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Ethyl 2-benzyl-2-nitro-3-phenylpropanoate (3.4a) 
To a solution of ethyl nitroacetate 3.3 (1.0 g, 7.51 mmol) in dry DMF (5 mL) was 
added DIEA (2.0 g, 15.4 mmol) and Bu4N+Br– (0.24 g, 0.75 mmol).  To this clear yellow 
solution, benzyl bromide (2.6 g, 15.4 mmol) was added and the reaction spontaneously 
warmed to 60 °C over 5 min.  After 20 min., DIEA•HBr precipitated out of solution.  
After 1 h, the solution was filtered to remove DIEA•HBr, the salt was washed with Et2O 
(100 mL), and the combined filtrates were washed with H2O (5 x 50 mL).  The organic 
layer was dried (Na2SO4) and evaporated at 0 OC to provide a yellow oil, which was of 
sufficient purity to be used in further reactions or could be purified to homogeneity by 
silica gel chromatography using Et2O-pentane (1:4) to provide a white solid. Yield, 1.48 
g (63%); mp 81-82 OC; 1H NMR (250 MHz, DMSO-d6) δ 7.38-7.22 (m, 10H), 4.10 (q, J 
= 7.1 Hz, 2H), 3.52 (d, J = 14.2 Hz, 2H), 3.46 (d, J = 14.2 Hz, 2H), 1.07 (t  J = 7.1 Hz, 
3H); 13C NMR (60 MHz, CDCl3) δ 166.5, 133.4, 130.3, 128.8, 128.0, 97.4, 62.9, 40.2, 
13.7; HRMS (FAB) calcd for C18H19NO4 (M + H)+ 314.1392, found 314.1395. Anal. 
Calcd for C18H19NO4: C, 68.99; H, 6.11; N, 4.47. Found: C, 69.09; H, 5.94; N, 4.32. 
Ethyl 2-nitro-2-(4-nitrobenzyl)-3-(4-nitrophenyl)propanoate (3.4b) 
To a solution of ethyl nitroacetate 3 (1.0 g, 7.51 mmol) in dry DMF (5 mL) was 
added Bu4N+Br- (0.24 g, 0.75 mmol) and 4-nitrobenzyl bromide (3.3 g, 15.4 mmol). To 
this cooled solution, DIEA (2.0 g, 15.4 mmol) was added dropwise and the solution was 
allowed to stir for 2 hrs. The resulting solution was diluted with diethyl ether (100 mL) 
and washed successively with 1N HCl (2 x 15 mL), saturated aqueous sodium carbonate 
solution (2 x 15 mL), and water (5 x 15 mL).  The solvent was removed in vacuo and the  
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resulting light yellow solid was recrystallized from ethanol to provide 2.27 g (75%) of 
3.4b as white crystals. mp 194-196 OC; 1H NMR (250 MHz, DMSO-d6) δ 8.21 (d, J = 
8.74 Hz, 4H), 7.51 (d, J = 8.74 Hz, 4H), 4.11(q, J = 7.1 Hz, 2H), 3.74 (d, J = 14.2 Hz, 
2H), 3.70 (d, J = 14.2 Hz, 2H), 1.05 t, J = 7.1 Hz, 3H); 13C NMR (60 MHz, DMSO-d6) δ 
165.0, 147.1, 141.1, 131.6, 123.4, 96.9, 63.0, 39.6, 13.3;  HRMS (FAB) calcd for 
C18H17N3O8 (M + H)+ 404.1094, found 404.1094. Anal. Calcd for C18H17N3O8: C, 53.60; 
H, 4.25; N, 10.42. Found: C, 53.40; H, 4.51; N 10.31. 
Ethyl 2-(4-cyanobenzyl)-2-nitro-3-(4-cyanophenyl)propanoate (3.4c) 
This compound was prepared from 4-cyanobenzyl bromide in 82% yield by 
using the same procedure as described for 3.4b. mp 138-139 OC; 1H NMR (250 MHz, 
DMSO-d6) δ 7.83 (d, J = 8.3 Hz, 4H), 7.41(d, J = 8.3 Hz, 4H), 4.08 (q, J = 7.1 Hz, 2H), 
3.76 (d, J = 14.2 Hz, 2H), 3.69 (d, J = 14.2 Hz, 2H), 1.03t, J = 7.1 Hz, 3H); 13C NMR (60 
MHz, DMSO-d6) δ165.0, 139.0, 132.3, 131.2, 118.5, 110.7, 96.9, 62.9, 39.9, 13.3; 
HRMS (FAB) calcd for C20H17N3O4 (M + H)+ 364.1297, found 364.1298. Anal. Calcd 
for C20H17N3O4: C, 66.10.; H, 4.72; N, 11.56. Found: C, 65.93; H, 4.97; N 11.55. 
Ethyl 2,2-bis(methylcarboxybenzyl)-2-nitroacetate (3.4d) 
This compound was prepared from methyl 4-(bromomethyl)benzoate in 72% 
yield by using the same procedure as described for 3.4b. mp 116-117 OC; 1H NMR (250 
MHz, DMSO-d6) δ 8.01-7.97 (m, 4H), 7.26-7.21 (m, 4H), 4.14 (q, J = 7.2 Hz, 2H), 3.92 
(s, 6H), 3.53 (s, 4H), 1.13 (t, J = 7.2 Hz, 3H); 13C NMR (60 MHz, DMSO-d6) δ 165.8, 
165.2, 138.7, 130.6, 129.2, 129.0, 96.9, 62.8, 52.1, 39.9, 13.3; HRMS (FAB) calcd for 
C22H23NO8 (M + H)+ 430.1502, found 430.1492. Anal. Calcd for C22H23NO8: C, 61.53;  
H, 5.40; N, 3.26. Found: C, 61.66; H, 5.62; N 3.26. 
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Bis(tert-butyl)-3-ethylcarboxy-3-nitroglutarate (3.4e) 
This compound was prepared from tert-butyl bromoacetate in 79% yield by using 
the same procedure as described for 3.4b. 1H NMR (250 MHz, CDCl3) δ 4.25 (q, J = 7.2 
Hz, 2H), 3.42 (d, J = 16.8 Hz, 2H), 3.30 (d, J = 16.8 Hz, 2H), 1.42 (s, 18 H), 1.24 (t, J = 
7.2 Hz, 3H); 13C NMR (60 MHz, CDCl3) δ 167.4, 165.0, 90.0, 82.6, 63.5, 39.9, 28.1, 
13.9; Anal. Calcd for C16H27NO8: C, 53.18; H, 7.53; N, 3.88. Found: C, 53.04; H, 7.33; 
N 3.81. 
Ethyl 2,2-bis(allyl)-2-nitroacetate (3.4f) 
This compound was previously prepared by Pd-mediated approaches.3.42 In this 
work 3.4f was prepared from allyl iodide by using the same procedure as described for 
3.4a followed by flash chromatography (hexane-ether, 1:3) to provide 3.4f in 45 % yield. 
1H NMR (250 MHz, CDCl3) δ 5.68-5.57 (m, 2H), 5.24-5.17 (m, 4H), 4.27 (q, J = 7.2 Hz, 
2H), 2.97-2.90 (m, 4H), 1.29 (t, J = 7.2 Hz, 3H); 13C NMR (60 MHz, CDCl3) δ 166.8, 
129.5, 121.6, 95.0, 62.9, 38.2, 14.1; MS (FAB) calcd for C10H15NO4Na (M + Na)+ 236.1, 
found 236.1. Anal. Calcd for C10H15NO4: C, 56.32; H, 7.09; N, 6.57. Found: C, 56.41; 
H, 6.98; N 6.53. 
Ethyl 2,2-bis(2-phenylsulfonyl ethyl)-2-nitroacetate (3.4g) 
To a solution of ethyl nitroacetate (0.4g, 3.0 mmol) in acetonirile (5 mL) was 
added DIEA (0.79 g, 6.15 mmol) and tetraethylammonium bromide (0.09 g, 0.3 mmol). 
To this solution, phenyl vinylsulfone (1.03 g, 6.15 mmol) was added dropwise and the 
solution was stirred at room temperature for 30 hrs. The acetonitrile was then removed in  
vacuo and the residue was dissolved in ethyl acetate (25 mL). The resulting solution was 
washed with 10% aqueous K2CO3 (2 x 10 mL), dried over anhydrous sodium sulfate, 
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and the solvent was removed in vacuo to give 3.4g as a light yellow solid. Yield, 0.98 g 
(70%). mp 88- 89 OC; 1H NMR (250 MHz, CDCl3) δ 7.92-7.59 (m, 10H), 4.25 (q, J = 
7.1 Hz, 2H), 3.17-3.10 (m, 4H), 2.60-2.53 (m, 4H), 1.26 (t, J = 7.1 Hz, 3H); 13C NMR 
(60 MHz, CDCl3) δ 164.3, 138.1, 134.2, 129.5, 127.8, 92.8, 63.6, 49.3, 26.6, 13.3; 
HRMS (FAB) calcd for C20H23NO8S2 (M + H)+ 470.0977, found 470.0936. Anal. Calcd 
for C20H23NO8S2: C, 51.16; H, 4.94; N, 2.98; S, 13.66. Found: C, 51.11; H, 5.07; N, 
3.00; S, 13.51. 
Bis(tert-butyl)-4-ethylcarboxy-4-nitropimelate (3.4h) 
 This compound was prepared from tert-butyl acrylate in 89% yield by using the 
same procedure as described for 3.4g. 1H NMR (250 MHz, DMSO-d6) δ 4.24 (q, J = 7.1 
Hz, 2H), 2.41-2.20 (m, 8H), 1.40 (s, 18H), 1.21 (t, J = 7.1 Hz, 3H); 13C NMR (60 MHz, 
DMSO-d6) δ 170.3, 165.8, 94.5, 80.3, 62.9, 29.0, 28.3, 27.6, 13.5;  HRMS (FAB) calcd 
for C18H31NO8 (M + H)+ 390.2128, found 390.2118. Anal. Calcd for C18H31NO8: C, 
55.51; H, 8.02; N, 3.60. Found: C, 55.31; H, 7.83; N, 3.87.  
4-Ethylcarboxy-4-nitropimelonitrile (3.4i) 
This compound was prepared from acrylonitrile in 87% yield by using the same 
procedure as described for 3.4g. 1H NMR (250 MHz, DMSO-d6) δ 4.27 (q, J = 7.1 Hz, 
2H), 2.70-2.54 (m, 8H), 1.24 (t, J = 7.1 Hz, 3H); 13C NMR (60 MHz, DMSO-d6) 
δ 164.7, 118.9, 93.2, 63.5, 28.5, 13.4, 11.7; HRMS (FAB) calcd for C10H13N3O4Na (M + 
Na)+ 262.0804, found 262.0809. Anal. Calcd for C10H13N3O4: C, 50.20; H, 5.48; N, 
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Figure 3.8 Synthesis of Fmoc-protected ααAAs. 
3.4.2 Ethyl 2,2-Dibenzylglycine Ester (3.5a) 
To a solution of nitro ester 3.4a (1.0 g, 3.19 mmol) in glacial AcOH (15 mL) at 
15 OC, Zn dust (0.63 g, 9.57 mmol) was added in several portions over 1 h.  The 
resulting mixture was allowed to warm to room temperature and vigorously stirred for 
24 h.  The solids were filtered off, washed with 1.0 M HCl (2 x 5 mL) and the combined 
filtrates were concentrated to an oil.  This oil was dissolved in a mixture of ethyl acetate 
(10 mL) and aqueous 1 M NaOH (15 mL), and stirred for 24 h.  The organic layer was 
separated, dried (MgSO4), and evaporated in vacuo to provide amino ester 3.5a as a 
white solid (0.73 g, 81% yield). mp 93-95 ºC; 1H NMR (250 MHz, DMSO-d6) δ 7.30-
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7.16 (m, 10H), 4.0 (q, J = 7.2 Hz, 2H), 3.18 (d, J = 12.9 Hz, 2H), 2.77 (d, J = 12.9 Hz, 
2H), 1.43 (s, 2H), 1.16 (t, J = 7.2 Hz, 3H),   13C NMR (60 MHz, DMSO-d6) δ 174.8, 
136.6, 130.0, 128.0, 126.6, 62.6, 60.3, 45.9, 14.0; HRMS (FAB) calcd for C18H21NO2 
(M + H)+ 284.1650, found 284.1637. Anal. Calcd for C18H21NO2: C, 76.29; H, 7.47; N, 
4.94. Found: C, 76.37; H, 7.31; N, 4.83. 
3.4.3 Ethyl 2,2-Bis(tert-butylcarboxylmethyl)glycine Ester (3.5e) 
To a solution of 3.4e (1.3 g, 3.92 mmol) in absolute ethanol (10 mL), glacial acid 
(1 mL) and a 50 % (w/w) slurry of Raney nickel in water (1.0 g) were added.  The 
reaction was hydrogenated over H2 gas (50 psi) for 24 hrs. The resulting solution was 
filtered carefully over Celite and the Celite cake washed with EtOH (30 mL). The 
solvent was removed in vacuo and the crude was dissolved in diethyl ether (30 mL). 
After washed with saturated sodium carbonate (30 mL) and brine, the organic fraction 
was dried over anhydrous sodium sulfate and rotary evaporated to yield 5e in 92% yield. 
1H NMR (250 MHz, CDCl3) δ 4.12 (q, J = 7.2 Hz, 2H), 2.67 (d, J = 15.5 Hz, 2H), 
2.48(d, J = 15.5 Hz), 2.26 (s, 2H), 1.37 (s, 18H), 1.20 (t, J = 7.2 Hz, 3H); 13C NMR (60 
MHz, CDCl3) δ 174.9, 169.7, 81.5, 61.5, 57.7, 45.0, 28.1, 14.2; Anal. Calcd for 
C16H29NO6: C, 57.99; H, 8.82; N, 4.23. Found: C, 58.07; H, 8.86; N, 4.03. 
3.4.4 Ethyl 2,2-Bis(tert-butylcarboxyethyl)glycine Ester (3.5h) 
This compound was prepared from 3.4h in 92% yield by using the same 
procedure as described for 3.5e. 1H NMR (250 MHz, DMSO-d6) δ 4.09 (q, J = 7.2 Hz, 
2H), 2.34-1.64 (m, 8H), 1.81 (s, 2H), 1.38 (s, 18H), 1.18 (t, J = 7.2 Hz, 3H); 13C NMR 
(60 MHz, DMSO-d6) δ 175.2, 172.0, 79.5, 60.4, 59.2, 34.2, 29.8, 27.6, 14.0; MS (FAB) 
calcd for C18H33NO6 359.46 , found 359.35. 
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3.4.5 Ethyl 2,2-Bis(tert-butylcarboxyethyl)-N-Hydroxyglycine Ester (3.6h) 
To a solution of 3.4h (1.0 g, 2.57 mmol) in absolute ethanol (15 mL), 10 % 
(w/w) palladium on carbon (0.1 g) was added carefully. The reaction was hydrogenated 
over H2 gas (50 psi) for 24 hrs. The resulting solution was filtered carefully over Celite 
and the Celite cake washed with EtOAc (30 mL). The organic filtrate was dried over 
anhydrous sodium sulfate and rotary evaporated to yield 3.6h in 97% yield. 1H NMR 
(250 MHz, DMSO-d6) δ 7.23 (s, 1H), 5.69 (s, 1H), 4.06 (q, J = 7.2 Hz, 2H), 2.17-2.13 
(m, 4H), 1.74-1.70 (m, 4H), 1.37 (s, 18H), 1.17 (t, J = 7.2 Hz, 3H); 13C NMR (60 MHz, 
DMSO-d6) δ173.6, 172.0, 79.5, 66.6, 29.1, 27.7, 26.3, 14.0; MS (FAB) calcd for 
C18H33NO7 (M + H)+ 376.47, found 376.77. 
3.4.6 2,2-Dibenzylglycine (3.1a) 
A suspension of 3.5a (2.0 g, 7.1 mmol) in 2 M KOH (50 mL) and ethanol (25 
mL) was refluxed under N2 for 24 h.  The resulting mixture was concentrated to 20 mL 
in vacuo and the mixture was acidified to pH 6.5 with concentrated HCl.  The white 
precipitate was filtered, washed with water (5 mL) and dried to provide the amino acid 
3.1a (1.58 g, 6.2 mmol) in 88% yield (mp > 300 °C).  1H NMR (250 MHz, CD3OD) δ 
7.27 (bs, 10H), 3.36 (d, J = 13.3 Hz, 2H), 2.85 (d, J = 13.3 Hz, 2H), 1.27 (s, 2H), 
HRFAB-MS calcd exact mass [M + Na]+ 278.1157, obsd 278.1159; HRMS (FAB) calcd 
for C16H17NO2Na (M + Na)+ 278.1157, found 278.1159. Anal. Calcd for C16H17NO2: C, 
75.27; H, 6.71; N, 5.48. Found: C, 75.34; H, 6.64; N, 5.30. 
3.4.7 2,2-Bis(tert-butylcarboxymethyl)glycine (3.1e) 
To a solution of 3.5e (2.0 g, 6.03 mmol) in ethanol (20 mL) was added LiOH (0.4 
g, 18.1 mmol) in water (10 mL). The reaction was stirred at 50 OC for 3 hrs followed by 
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the same work-up procedure as described for 3.1a to provide the amino acid as a white 
solid. Yield, 1.53 g (82%). 1H NMR (250 MHz, DMSO-d6) δ 2.78 (d, J = 17.2 Hz, 2H), 
2.69 (d, J = 17.2 Hz), 1.37 (s, 18H); 13C NMR (125 MHz, DMSO-d6) δ 175.8, 173.7, 
85.7, 62.7, 43.3, 30.5; HRMS (FAB) calcd for C14H25NO6 (M + H)+ 304.1760, obsd 
304.1760. 
3.4.8 Nα-(9-Fluorenylmethoxycarbonyl)-2,2-Dibenzylglycine (3.7a) 
TMSCl (0.85 g, 7.84 mmol) was  added to a suspension of amino acid 3.1a (1.0 
g, 3.92 mmol) in dry CH2Cl2 (20 mL) and refluxed under N2 for 8 h.  The mixture was 
cooled to 0 °C, and DIEA (1.01 g, 7.84 mmol) and Fmoc-Cl (1.01 g, 3.92 mmol) were 
added.  The reaction was allowed to warm to 25 °C and stirred for 30 h.  The resulting 
mixture was concentrated in vacuo to provide a yellow solid which was dissolved in 
aqueous 10% NaHCO3.  This solution was washed with Et2O (3 x 15 mL), the aqueous 
layer was acidified to pH 2.0 with HCl, and extracted with EtOAc (3 x 35 mL).  The 
combined EtOAc layers were dried (MgSO4) and concentrated in vacuo to provide a 
light yellow solid.  The crude product was purified by crystallization from Et2O-hexanes 
to give the protected ααAA 3.7a as a white solid (1.5 g, 80% yield). mp 184-185 °C;  1H 
NMR (250 MHz, CDCl3) δ 7.81-7.10 (m, 18H), 5.50 (s, 1H), 4.49 (d, J = 7.0 Hz, 2H), 
4.29 (t, J = 7.0 Hz, 1H), 3.90 (d, J = 13.6 Hz, 2H), 3.26d, J = 13.6 Hz, 2H); 13C NMR (60 
MHz, CDCl3) δ  177.2, 155.0, 144.2, 141.7, 136.1, 130.1, 128.8, 128.1, 127.5, 125.6,  
120.4, 67.1, 66.9, 47.7, 41.5; HRMS (FAB) calcd for C31H27NO4 (M + H)+ 478.2018, 
found 478.1996. Anal. Calcd for C31H27NO4: C, 77.96; H, 5.70; N, 2.93. Found: C, 





This compound was prepared from 3.1e in 71% yield by using the same 
procedure as described for 3.7a. 1H NMR (250 MHz, CDCl3) δ7.76-7.24 (m, 8H), 6.33 
(s, 1H), 4.32 (d, J = 7.0 Hz, 2H), 4.20 (t, J = 7.0 Hz, 1H), 3.37 (d, J = 15.1 Hz, 2H), 2.85 
(d, J = 15.1 Hz, 2H), 1.38 (s, 18H); 13C NMR (60 MHz, DMSO-d6) δ 171.9, 168.4, 
153.9, 143.7, 140.7, 127.6, 127.0, 125.1, 120.1, 80.1, 65.6, 57.9, 46.5, 39.7, 27.6; Anal. 
Calcd for C29H35NO8: C, 66.27; H, 6.71; N, 2.66. Found: C, 66.48; H, 6.87; N 2.56. 
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CHAPTER 4 
 
SYNTHESIS OF NOVEL β-STRAND MIMICS AND ITS APPLICATION TO 




Development of small molecules that mimic the structures of bioactive peptides 
has gained increased interest in the past twenty years.4.1-4.4 The de novo design and 
synthesis of artificial peptides with well-defined secondary structures facilitates protein 
folding studies and offers the promises of creating pharmacologically useful analogues 
of bioactive peptides. One of the commonly studied molecules is the antimicrobial 
peptides that adopt helical structures induced by Cα,α-disubstituted amino acids 
(ααAA).4.3, 4.5 A number of ααAAs including α-aminoisobutyric acid (Aib) and 4-
aminopiperidine-4-carboxylic acid (Api) have been employed in the antimicrobial 
peptide design. Unlike helix mimics, β-strand mimics with the tendency to form 
interstrand hydrogen bonds have not been well investigated. β-sheets are important 
structural elements in proteins and are in involved in various biological processes such 
as protein polymerization, substrate recognition, and electron transfer.4.6-4.7  
It is believed that the oligomerization of monomeric β-amyloid peptide (Aβ) into 
insoluble fibrils plays a key role in the progression of Alzheimer’s disease (AD).4.8-4.11  
 
 
*Reprinted in part with permission from Organic Letters, 2002, Volume 4, pages 237-
240; Fu, Y. and Hammer, R. P., Efficient Acylation of the N-terminus of Highly 
Hindered Cα,α-Disubstituted Amino Acids via Amino Acid Symmetrical Anhydrides 
Copyright 2002 American Chemical Society. 
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Alzheimer’s disease is associated with gradually formed proteinaceous deposits, called 
amyloid plaques, which may displace and kill brain cells by triggering inflammation and 
by damaging the cell’s interiors.4.10-4.11 Deposition of insoluble amyloid fibrils as 
amyloid plaques in the neuropil is the key step in the pathogenesis of AD.4.10-4.13 The 
principle component of the amyloid fibril is β-amyloid peptide (Aβ), a hydrophobic 
peptide which exists either as anti-parallel or parallel β-sheet, or the mixture.4.14-4.15 
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Figure 4.1 Section of parallel β-sheet structure in amyloid fibril. 
 
reported two main pathways for amyloid fibril initiation and growth (Figure 4.2).4.16 
When Aβ is above a critical concentration (~ 10-30 µM), it will aggregate to form 
micelle (M) which can rearrange into protofibril (P). The further growth and aggregation 
of protofibril eventually lead to the formation of fibril (F). At lower concentration of Aβ, 
the presence of an alternative element is required to initiate the accumulation and 
aggregation of Aβ to form a protofibrillar-like species P’.  The gradual growth of P’ can 












Figure 4.2 Aβ initiation and growth. (A) Concentration of Aβ is above the critical 





 In practice, the surface of all species Αβ, M, P/P’ and F/F’ may be very similar, 
with at least one edge open allowing hydrogen-bond formation. We hypothesize that in 
the presence of “blocker” peptides, which could interact with F/F’, P/P’, M, and the 
single Aβ, the growth of Aβ to fibril may become reversible and the dissolution of Aβ 
from F (or its intermediates) may be promoted. The design of amyloidogenesis inhibitors 
is based on novel β-strand mimics, in which natural L-amino acids and Cα,α-
disubstituted amino acids with large side chains are at alternating sequence positions 
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Figure 4.3 Blocker peptide design. 
 
conformation.4.17-4.20 For example, crystal structure study revealed that Cα,α-
dibenzylglycine (Dbzg) exclusively adopted extended C5 conformation (Figure 4.4) in 
solid state.4.21-4.22 Incorporation of the sterically hindered ααAAs with C5 structure 
preference is likely to promote extended peptide backbone conformation. Alternating 
natural L-amino acids and ααAAs in the peptide chain allows hydrogen bonding on one 
edge, while blocking hydrogen bonding on the opposite edge. To test our hypothesis, we 
have proposed both parallel and anti-parallel blocker peptides of amyloid fibril based on 
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Figure 4.5 Blocker peptides based on amyloid fibril hydrophobic core. (A) Parallel  
blocker peptide; (B) Anti-parallel blocker peptide. 
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acids are the same as the amino acids in Aβ16-20, while the ααAAs are the achiral 
analogues of the natural amino acids in the hydrophobic core. The conformationally 
constrained blocker peptides are likely to adopt extended structures and interact with the 
hydrophobic core on opening edge of amyloid fibril based on “like likes like” residue 
relationship. 
 Preparation of the designed β-srand mimics is synthetically challenging, as the 
sterically hindered ααAAs inhibit efficient amide bond formation. The ααAAs with 
short side chains such as α-aminoisobutyric acid (Aib), Cα,α-diethylglycine (Deg), and 
Cα,α-dipropylglycine (Dpg) have been incorporated into peptides by a variety of 
methods, including standard carbodiimide protocols, urethane-protected N-carboxy 
anhydrides, activated oxazolones, amino acid fluorides, and HOAt-based uranium (e.g., 
HATU) and phosphonium salts (e.g., PyAOP).4.19, 4.23-4.31  Incorporation of more 
demanding ααAAs such as Cα,α-dibenzylglycine (Dbzg), Cα,α-diisobutylglycine (Dibg), 
or 2,2,6,6-tetramethylpiperdine-1-oxyl-4-carboxylic acid (TOAC) into peptides is more 
problematic. For example, incorporation of Dbzg or TOAC onto a growing peptide chain 
was readily accomplished by activated ααAA oxazolones or traditional HBTU coupling 
reagent.4.32-4.33 In contrast, acylation of the N-terminus of Dbzg or TOAC with 
DCC/HOBt, mixed anhydride, or HATU only gave low to moderate yields.4.32-4.34 Thus 
the difficulties in incorporating sterically hindered ααAAs into internal position of 
peptide chains mainly stem from the inefficient acylation of the ααAA N-termini.  
 Several other groups have previously found that secondary amino acids acylate 
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Figure 4.6 Structure of symmetrical anhydride. 
 
 
salts), but more readily react with symmetrical anhydrides in nonpolar solvents such as 
dichloromethane.4.35-4.36 The previous results offer a promise for developing novel 
strategy to acylate constrained ααAAs. In this work, preformed symmetrical anhydride 
(Figure 4.6) is employed to acylate N-terminus of sterically hindered ααAAs such as 
Dbzg and Dibg. Using the symmetrical anhydride method, a potential inhibitor of 
amyloid fibril is prepared. Also preliminary biological study is carried out to measure 
the inhibitor’s property against amyloid aggregation.  
4.2 Results and Discussion 
4.2.1 Acylation of N-terminus of Sterically Hindered ααAAs 
As part of our ongoing program aimed at conformationally restricted peptides 
containing ααAAs at alternating sequence positions, peptides DBZG-1 and DIBG-1 
were assembled using Fmoc-solid-phase synthesis. We have found that PyAOP (also see 
chapter 1 and Chapter 2) is a powerful reagent for incorporation of less hindered ααAAs 





Table 4.1 Coupling of Fmoc-Lys(Boc)-OH onto (A) H-Dbzg-Ala-Dpg-Glu(OtBu)-resin 
and (B) H-Dibg-Ala-resin.a 
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synthesis of peptide DBZG-1 and DIBG-1, we have found that coupling of Fmoc-Dbzg-
OH and Fmoc-Dibg-OH onto the N-terminus of Alanine using PyAOP at elevated 
temperature was relatively efficient. However, once Dbzg or Dibg was at the N-terminus 
of the peptide, the following acylation of the ααAAs became very difficult (Table 4.1, 
entries 1-8). In our work, coupling of Fmoc-Lys(Boc0-OH onto the N-terminus of Dbzg 
or Dibg using PyAOP in DMF was ineffective (Talbe 4.1, entry 1). When the coupling 
was performed in a low polarity solvent mixture (DCE-DMF, 1:1), improved but still 
low yields were obtained (Table 4.1, entries 2-4). The attempted acylation of N-terminus 
of Dbzg of Dibg using HATU also gave a low yield at room temperature, while the 
acylation of Dibg at 50 ºC resulted in a moderate yield (Table 4.1, entries 5-6). When an 
amino acid fluoride protocol was utilized,4.38 the acylation in DCE-DMF (1:1) gave low 
yields for both Dbzg and Dibg. Interestingly, when the acylations were carried out in a 
less polar solvent mixture of DCE-DMF (9:1), improved yields were obtained (Table 
4.1, entries 7-8). 
 Previous studies showed symmetrical anhydrides could readily acylate N-
substituted secondary amino acids in a nonpolar solvent such as CH2Cl2.4.35-4.36 In our 
hands we found that the symmetrical anhydride of Fmoc-Lys(Boc)-OH in CH2Cl2 in the 
absence of base gave an improved yield (62%) in the acylation of the Dibg-resin at room 
temperature (Table 4.1, entry 9). On the basis of our previous work, we found that the 
coupling could be improved at elevated temperatures. Thus, the symmetrical anhydride 
we prepared in CH2Cl2 was concentrated and redissolved in the higher boiling DCE-
DMF mixture. Now a 3 h coupling in DCE-DMF (9:1) at 50 ºC gave an acylating yield 
of 95% for the Dbzg-resin and 91% for the Dibg-resin (Table 4.1, entry 10). It was also 
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observed that activated mixed anhydride formed by BOP-Cl4.39 and Lys gave very good 
coupling yield at elevated temperature (Table 4.1, entry 14). It is not as yet understood 
why the symmetrical anhydride method is so much more efficient at acylating the 
sterically hindered Dbzg and Dibg residues than methods based on uranium, 
phosphonium salts, or amino acid fluorides. One possibility is that the symmetrical 
anhydride may possess an enhanced reactivity in the aprotic nonpolar solvent for which 

























Figure 4.7 Anchimeric assistance provided by the H-bond donation. 
 
this out in that coupling of the symmetrical anhydride in non-polar solvent gives higher 
yields than the couplings in more polar solvents (Table 4.1, entries 11-12). When the 
reaction of the symmetrical anhydride was performed in the more H-bond accepting 
solvent mixture of DCE–DMF (1:1) or in pure DMF, the coupling efficiency 
systematically decreased. The peptide DBZG-1 and DIBG-1 were prepared using the 
optimized coupling conditions and cleaved from the resin by 88% TFA and analyzed by 
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Figure 4.8 HPLC and MS profiles of DBZG-1. (A) HPLC profile of crude peptide 
DBZG-1; (B) MALDI-MS spectrum of the main peak on HPLC. For MS of DBZG-1, 
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Figure 4.9 HPLC and MS profiles of DIBG-1. (A) HPLC profile of crude peptide 
DIBG-1; (B) MALDI-MS spectrum of the main peak on HPLC. For MS of DIBG-1, m/z 
calcd. [M + Na]+ 408.5, obsd. 408.4. 
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4.2.2 Synthesis of Amyloid Blocker Peptide 
The proposed amyloid block peptides are analogous of hydrophobic core Aβ16-20, 
which contains ααAAs and L-amino acids at alternating sequence positions (Figure 4.5). 
In the sequence of parallel blocker peptide AMY-1, Phe, Val, or Lys is at either the C- or 





both termini of the ααAAs difficult. To optimize the yield of the peptide, three 
activation methods were utilized during the peptide assembly (Figure 4.10). The first six 
lysine residues were coupled to PAL-PEG-PS resin under PyAOP/DIEA/DMF coupling 
conditions on peptide synthesizer. The rest of amino acid residues were incorporated 
manually into the sequence. Dpg and Phe were incorporated into peptide using 
PyAOP/DIEA in DCE-DMF (1:1). Coupling of Fmoc-Dbzg-OH onto Phe was also 
performed using PyAOP at 50 ºC in which an 89% yield was obtained after 8 hours. In 
contrast, the coupling of Fmoc-Dibg-OH onto Val using PyAOP/HOAt at 50 ºC only 
gave a 58% yield after 12 hours. When the coupling of Fmoc-Dibg-OH onto Val was 
performed under HATU/HOAt conditions, an improved yield (81%) was obtained.  
 As we experienced before, once the Dbzg or Dibg was at the N-terminus of the 
peptide, the following acylation of the ααAAs was very difficult (Figure 4.11). 
Monitoring of the coupling of Fmoc-Val or Fmoc-Lys to the highly hindered N-terminus 
of Dbzg or Dibg, respectively, using PyAOP/HOAt or amino acid fluorides showed that 











































         



















































































Figure 4.11 Monitoring the acylation of N-terminus of ααAAs. (A) Coupling of Fmoc-
Val-residue onto H-Dbzg-Phe-Dpg-(Lys(Boc))6-PAL-PEG-PS; (B) coupling of Fmoc-
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Figure 4.12 HPLC and MS profiles of AMY-1. (A) HPLC profile of crude peptide 
AMY-1; (B) MALDI-MS spectrum of the main peak on HPLC. For MS of AMY-1, m/z 






































Figure 4.13 Temperature-dependence of the CD spectra of AMY-1. Conditions: 250 µM 
peptide in 10 mM phosphate buffer, pH 7.0. 
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Coupling of Fmoc-Val-OH or Fmoc-Lys-OH to the N-terminus of Dbzg or Dibg under 
HATU/HOAt conditions also gave low yields (32%, 35%) after 15 hours. In contrast, the 
acylation using readily available Fmoc amino acid symmetrical anhydrides in low 
polarity solvent without base resulted in excellent coupling yields. The deblocked 
peptide was obtained in high quality and good yield as verified by HPLC and by 
MALDI-MS (Figure 4.12). 
 The conformational preference of the β-strand mimic in aqueous solution is an 
important property of the designed inhibitor, since polymerization could turn the 
inhibitor itself into problematic aggregates. If the β-strand mimic aggregates, it is likely 
to interact with another strand to form the β-sheet structure. The conformational 
behavior of AMY-1 was studied by circular dichroism spectroscopy in phosphate buffer 
(Figure 4.13). There is a positive band at 200 nm and two negative bands at 190 and 230 
nm, respectively in the CD spectra. The overall shape of the CD spectra indicated the 
content of β-turn secondary structure in aqueous solution,4.40-4.42 like peptide DPG-2 
described in Chapter 2. Upon heating, the band at 190 nm became slightly weaker, and 
the bands at 200 nm and 230 nm were almost unchanged, indicating a stable content of 
the secondary structure.  
4.2.3 Preliminary Biological Study of Inhibitor AMY-1 
The design of the amyloid inhibitor is based on the  central hydrophobic core 
Aβ16-20, which is an essential core for Aβ fibrillogenesis.4.43-4.44 The blocker peptide 
which contains L-amino acids and ααAAs at alternating sequence positions is likely to 
adopt extended conformation and interact with the hydrophobic core on fibril opening 
strand based on “like likes like” residue relationship.  The presence of ααAAs at  
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alternation sequence positions allows hydrogen bonding on one side of the β-strand 
mimics, while blocking further addition from the opposite side thus preventing the 
growth the amyloid aggregates. The incorporation of oligolysine at the C-terminus could 
also prevent elongation of the amyloid β-structures4.45 and increase the inhibitor’s 
solubility in aqueous solution. 
 The inhibitor’s efficacy was analyzed by Jed Aucoin in Dr. McCarley’s group. In 
the study with atomic force microscopy (AFM), a mixture of AMY-1 to Aβ10-35 at a ratio 
9:1 was compared to a control of only Aβ10−35. The control sample that contained 50 µM 
Aβ10-35 in 15 mM phosphate buffer and 150 mM NaCl at pH 7.3 was incubated at 37 ºC 
for 14 hours. Figure 4.13 shows the incubated control sample adsorbed onto mica.4.46 
There were a number of fibril-like species with varying length between 560-700 nm and 
a range of aggregate height of 2-28 nm. When AMY-1 was co-incubated with Aβ10-35 at 
a ratio of 9:1 under the same conditions as the control, the fibril formation was not 
present in the sample (Figure 4.13).4.46 Instead only a few spherical aggregates with 50-
70 nm width were obtained. 
 In another experiment, the inhibitor’s efficacy was analyzed by measurement of 
samples consisting of AMY-1 and Aβ10-35 at other ratios. The control sample that 
contained 300 µM Aβ10-35 in 116 mM NaCl at pH 7.5 was incubated at room 
temperature for 9 days. It displayed a number of large aggregates with 1.5 µm in width 
and 143 nm in height (Figure 4.14).4.46 In contrast, significant differences in aggregation 
were observed in the samples containing AMY-1 and Aβ10-35 at 3:1 and 1:1 ratio 




        
(B) 
(A) 
Figure 4.14 Effects of AMY-1 on aggregation of Aβ10-35 at 9:1 ratio at 37 ºC. (A) 
Aβ10−35 (50 µM) was incubated in PBS (pH 7.3) and 150 mM NaCl for 14 h at 37 ºC. (B) 

















Figure 4.15 Effects of AMY-1 on aggregation of Aβ10-35 at 3:1 and 1:1 ratio at 25 ºC. 
(A) Aβ10−35 (300 µM) was incubated in 18 mM PBS (pH 7.5) and 116 mM NaCl for 9 
days at 25 ºC; (B) AMY-1 (300 µM) and Aβ10−35 (300 µM) were incubated under the 
same condition as above; (C) AMY-1 (900 µM) and Aβ10−35 (300 µM) were incubated 




nm in width and 50 nm in height; the 1:1 ratio samples contained some small particles 
with about 190 nm in width and 15 nm in height. 
 The preliminary study indicates that AMY-1 can effectively minimize the 
aggregation of amyliodgenic Aβ10-35. Since the inhibitor and Aβ10-35 were mixed together 
at the beginning of the incubation, it is likely that the blocker peptide attached to the 
target site on monomeric amyloid peptide and/or growing amyloid species thus blocked 
the further aggregation. However, we cannot rule out the possible competing pathway in 
which the blocker peptide interacted with formed fibrils and promoted amyloid fibril 
dissolution. The inhibitor’s property of dissociating fibrils can be analyzed by adding 
AMY-1 to pre-incubated Aβ solution under optimized conditions.  
4.3 Conclusions 
Polymerization of amyloid β-peptides is a major feature in the pathological 
process of Alzheimer’s disease. It is believed that hydrophobicity facilitates monomeric 
Aβ interaction and thereby promotes amyloid fibril formation. The design of inhibitor 
AMY-1 is based on the central hydrophobic core Aβ16-20. The characteristic feature of 
the inhibitor is that it contains natural L-amino acids and constrained ααAAs at 
alternating sequence positions. 
AMY-1 was successfully assembled using solid-phase peptide synthesis, where 
amino acid symmetrical anhydride protocol was utilized to efficiently acylate the N-
terminus of highly hindered ααAAs. The preliminary aggregation study shows 
impressive inhibitory activity of AMY-1. The application of AMY-1 and its analogs to 
anti-aggregation study offers the promise of understanding the inhibition mechanism of 
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anti-fibrillogenesis with β-strand mimics and may facilitate the development of novel 
inhibitors which prevent amyloidogenesis in vivo in Alzheimer’s disease.  
4.4 Experimental 
4.4.1 Peptide Synthesis and Purification 
Peptides DBZG-1 and DIBG-1 were manually synthesized on Fmoc-PAL-PEG-
PS resin. All coupling before acylation of Dbzg or Dibg were efficiently carried out 
using PyAOP in DCE-DMF (1:1). Conditions: PyAOP, 4 equiv; DIEA, 8equiv; Fmoc 
amino acids, 4 equiv (0.3M). Deblock, piperidine: DBU: DMF (5:2:93). Coupling of 
Fmoc-Lys(Boc)-OH onto resin-bounded peptide was performed on 0.1 mmol scale resin 
under different conditions. (i) Coupling using PyAOP and DIEA was carried out under 
the same conditions as described above. Yield, 20% for DBZG-1 and 22% for DIBG-1. 
(ii) Coupling of Fmoc-Lys(Boc)-OH (0.4 mmol, 4 equiv) was performed using PyAOP 
(0.4 mmol, 4 equiv), HOAt (0.4 mmol, 4 equiv), and DIEA (0.8 mmol, 8 equiv) in DCE-
DMF (1:1) at room temperature. Yield, 25% for DBZG-1 and 26% for DIBG-1. (iii) The 
acylation of N-terminal Dbzg and Dibg with Fmoc-Lys(Boc)-OH (0.2 mmol, 4 equiv) 
using HATU (0.2 mmol, 4 equiv) and DIEA (0.4 mmol, 8 equiv) and DIEA (0.4 mmol, 
8 equiv) in DMF at room temperature gave an 18% for DBZG-1 and 32% for DIBG-1. 
(iv) The acylation using Fmoc-Lys(Boc)-F (0.2 mmol, 4 equiv), DIEA (0.2 mmol, 4 
equiv) in DCE-DMF (9:1) at 50 ºC gave 46% yield for DBZG-1 and 50% yield for 
DIBG-1. (v) Symmetrical anhydride was prepared by treatment of 2 equiv of Fmoc-
Lys(Boc)-OH with 1 equiv of DCC in CH2Cl2 at room temperature or 2h and the 
precipitated DCU was removed by filtration. The symmetrical anhydride coupling 
method was performed by adding preformed (Fmoc(Boc))2O (0.3 mmol, 3 equiv) to the 
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resin-bound peptide in DCE-DMF (9:1) in the absence of base. The reaction was carried 
out at 50 ºC to give a 95% coupling yield for DBZG-1 and 91% yield for DIBG-1. (vi) 
The mixed anhydride was prepared by treatment of 1 equiv of Fmoc-Lys(Boc)-OH with 
1 equiv of BOP-Cl with the presence of 1 equiv of DIEA in CH2Cl2 at 0 ºC for 1h. The 
concentrated mixed anhydride was taken up in proper solvent for coupling. The coupling 
of the mixed anhydride (0.3 mmol, 3 equiv) to N-terminal Dbzg and Dibg in DCE-DMF 
(9:1) at 50 ºC gave 88% yield for DBZG-1.  
For the synthesis of AMY-1, the first six Lys residues were coupled to PAL-
PEG-PS resin under PyAOP/DIEA/DMF coupling conditions on a Perseptive 
Biosystems Peptide Synthesizer 9050. The rest of amino acid residues were incorporated 
manually into the sequence. Dpg, Phe, and Dbzg were incorporated into sequence using 
PyAOP/DIEA in DCE-DMF (1:1) under the same conditions for DBZG-1; Val residue 
was coupled to N-terminus of Dbzg via amino symmetrical method under the same 
conditions for DBZG-1; Dibg was coupled to Val using HATU (4 equiv), HOAt (4 
equiv), DIEA (8 equiv), and Fmoc-Dibg-OH (4 equiv, 0.3M) in DCE-DMF (1:1) at 50 
ºC; Lys residue was coupled to Dibg via symmetrical anhydride at 50 ºC.  
After the peptide synthesis, the resin was treated with standard cleavage solution 
(trifluoroacetic acid : triisopropylsilane : water: phenol, 8.8 : 0.2 : 0.5 : 0.5) at room 
temperature for 2h to cleave the peptide from the solid support. After filtration, the 
filtrate was diluted with cold 40% acetic acid solution, washed with cold diethyl ether (5 
x 40 mL), and lyophilized to yield to crude peptides. 
The crude peptides were purified by reverse phase HPLC using Waters Deltapak 
C4 column (15 µm, 300 A, 25 x 100mm). The flow rate was 1 mL/Min for analytical 
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HPLC and 10 mL/min for preparative HPLC. For all peptides, solvent A was 0.05% 
TFA in water, solvent B was 0.05% TFA in acetonitrile. The identity and purity of the 
peptides was confirmed by quantitative amino acid analysis and matrix-assisted laser 
desorption/ionization mass spectrometry. For peptide DBZG-1, the purification was 
carried out using a linear gradient from 10-60% B over 50 minutes, tR = 42.5 min, 
overall yield 68%; MALDI [M + Na]+ m/z calcd. 746.9, obsd. 747.1. For peptide DIBG-
1, the purification was performed with a linear gradient from 10-50% B over 40 minutes, 
tR = 10.1 min, overall yield 81%; MALDI [M + Na]+ m/z calcd. 408.5, obsd. 408.4. 
Purification of AMY-1 was carried out using a linear gradient form 10-70% B over 60 
minutes, tR = 42.9 min, overall yield 61%. MALDI [M + Na]+ m/z calcd. 1731.3, obsd. 
1731.4. 
4.4.2 Circular Dichroism 
Circular dichroism measurements were performed on a (+)-camphor sulfonic 
acid calibrated Aviv 60DS spectrophotometer. The samples were prepared as stock 
solutions in buffer and diluted to the desired concentration in proper solution for 
measurements. The CD measurements were recorded over a 250-180 nm range using a 
quartz cell of 1 mm path length, 1 nm bandwidth, 20 nm/min scan speed, and a time 
constant of 0.5 s. Molar ellipticity was calculated using the formula [θ] = 
[θ]obs(MRW/10cd), where [θ]obs is the mean residue molecular weight of the peptide 
(molecular weight divided by the number of peptide bonds), c is the concentration of the 
sample in mg/mL, and d is the optical path length of the cell in cm. All spectra were 
corrected for buffer (or solvent) contributions and presented in unit of molar ellipticity. 
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4.4.3 Atomic Force Microscopy 
The stock solution, controls, and samples created from the stock were prepared 
for AFM analysis on the same day. The sample was placed onto a magnetic puck and 
placed on top of the piezoelectric scan tube within the AFM instrument. Scans up to 125 
µm2 can be captured with the vendor’s (Digital Instrument) software. After capturing the 
image, a flatten procedure was performed and a top view allows the size of the 
aggregates to be determined. The heights of these aggregates were determined using 
bump analysis. 
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CHAPTER 5 
 
SUMMARY AND FUTURE STUDIES 
 
5.1 Discussion 
 This dissertation has focused on design, synthesis, and structural analysis of short 
peptides containing constrained Cα,α-disubstituted amino acid (ααAAs). Sterically 
hindered ααAAs such as Cα,α-dibenzylglycine (Dbzg) and Cα,α-diisobutylglycine (Dibg) 
have a strong tendency to adopt energetically favored extended structures.5.1-5.2 
Incorporation of these sterically hindered ααAAs into alternating peptide sequence 
position could induce extended conformations, which possess one blocked edge and one 
opening edge for H-bonding formation. Sterically hindered ααAAs have not been 
commonly used in de novo peptide design, mainly due to the difficulty in ααAA 
preparation and peptide assembly. Development of new strategies to overcome the 
problems associated with amino acid synthesis and coupling process is significant in 
peptide research. In this study, the main application of the extended β-strand mimics is 
the development of β-sheet blocker peptides, which could be utilized to prevent amyloid 
fibril assembly. Synthesis of the amyloid blocker peptides and study of their 
conformational and biological properties is crucial for potential therapeutical agent 
development.  
 Chapter 2 of this dissertation describes the synthesis and conformational studies 
of short peptides containing Cα,α-dipropylglycine (Dpg). Based on the fact the extended 
C5 conformation is energetically favored over helical conformation in Dpg 
derivatives,5.3-5.6  a number of pentapeptides containing Dpg at alternating sequence 
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position were designed. In these peptides, glutamic acid and/or lysine were placed at 
each end of the sequence to probe the impact of side chain interaction on peptide 
conformational preference. All peptides were assembled by solid-phase peptide 
synthesis using Fmoc strategy. It was found that PyAOP was a powerful coupling 
reagent for incorporation of Dpg into peptide internal positions at elevated temperature. 
The experimental results also showed that acylation of N-terminus of Dpg was more 
difficult than coupling at the C-terminus.5.7-5.8 
 Peptide conformational behavior was systematically studied by circular 
dichroism (CD) and Nuclear Magnetic Resonance spectroscopy (NMR). The Dpg 
peptide containing Lys and Glu at each end of the sequence exhibited stronger ellipticity 
values than the peptides whose termini are both Glu or Lys. Side chain interaction was 
also probed in pH dependence CD study where peptide DPG-2 exhibited systematically 
decreased CD bands as the buffer solution goes from neutral to acidic. In both CD and 
NMR studies, the Dpg peptides showed characteristic data indicating β-turn structures. 
Based on NOE measurement, the solution structure of Dpg peptide was generalized and 
energy minimized. It contained two consecutive β-turns whose H-bonds are stabilized by 
side chain interaction between lysine and glutamic acid. It has been reported that high 
alkyl analogues of Aib, such as Dpg, can accommodate either fully extended or helical 
conformation, depending on peptide sequence, length, and environment.5.9 In our peptide 
design, the Dpg residues might be in a “helix-friendly” context, so the Dpg residues 
could comfortably fit into the helical (turn) conformation. To induce extended backbone 
structure, Dpg needs to be incorporated into peptides whose residues have a strong 
tendency to adopt extended conformation (Table 5.1).  Cα,α-dibenzylglycine (Dbzg) is 
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Table 5.1 Proposed β-strand mimics containing ααAAs. 
Peptide                              Sequence 
DPG-6 Ac-Glu Dpg Val Dpg Lys-NH2 
DPG-7 Ac-Glu Dpg Val Dpg Glu-NH2 
DPG-8 Ac-Lys Dpg Val Dpg Lys-NH2 
DBZG-2 Ac-Glu Dbzg Val Dpg Lys-NH2 
DBZG-3 Ac-Lys Dbzg Val Dpg Glu-NH2 
DBZG-4 Ac-Glu Dbzg Tyr Dbzg Lys-NH2 
DBZG-5 Ac-Glu Dbzg Val Dbzg Lys-NH2 
 
 
known for it overwhelming property to induce C5 conformation in solid state,5.1-5.2 while 
valine has been found in a number of extended peptides.5.9 Incorporation of Val and/or 
Dbzg into peptide sequence will provide interesting β-strand mimic samples for 
conformational studies.  
 Chapter 3 describes the synthesis of sterically hindered ααAAs via ethyl 
nitroacetate. Nitroacetate is a useful synthon for preparation of a number of important 
organic compounds.5.10-5.11 Nitroacetates possess a high reactive α-carbon which can be 
readily dialkylated under base-catalyzed mild conditions. It was observed that 
nucleophilic addition to Cα-deprotonated nitroacetate was greatly enhanced with the 
presence of a catalytic amount of tetraammonium alkyl halide. The high yields for these 
dialkylation reactions made this a very useful synthetic route upon which orthogonally 
protected ααAAs were obtained. This method has been shown to be successful for the 
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synthesis of highly sterically hindered Fmoc-Dbzg-OH, as well as the synthesis of 
chemically sensitive ααAAs, such as Nα- and side chain-protected tetrafunctional 
derivatives (Fmoc-Bcmg(OtBu)2-OH). The nucleophilic addition to the nitroacetate 
anion may be extended to a variety of electrophiles, including benzyl aldehyde and α,β-
, γ,δ-unsaturated nitroolefin. Described below is a suggested synthetic approach to the 
ααAA analogue of lysine via nucleophilic addition of ethyl nitroacetate with α,β-, γ,δ-
unsaturated nitroolefin (Figure 5.1).  Based on previously reported procedure of 
mono-alkylation of nitroacetate with nitrodiene,5.10 the dialkylation will be 






























Figure 5.1 Synthetic approach towards the ααAA analogue of lysine. 
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product of the dialkylation is the derivative from addition at the δ position of the 
nitrodiene. Michael type addition at the β position of the diene may also occur 
and result in mixed dialkylated products.  Next, the primary nitro groups and 
double bonds on the side chains of the derivative will be hydrogenated, then 
protected by t-butyloxycarbonyl group. Subsequent hydrogenation of the tertiary 
aliphatic nitro group with Raney Nickel and hydrolysis of the ethyl acetate will give 
the free amino acid which should allow for the preparation of orthogonally protected 
ααAA analogue of lysine. 
 Chapter 4 of this dissertation addresses the synthesis of novel β-strand mimics 
and its application to the development of potential inhibitors of amyloid fibril. 
Incorporation of sterically hindered ααAAs such Dbzg into alternating peptide sequence 
position imposed specific constraints on peptide backbone and thus induced extended 
conformation. Coupling with sterically demanding ααAAs was difficult, mainly due to 
the proximity of N- and C- terminus to the congested α-carbon in ααAA. It was 
observed that coupling at N-terminus of ααAA was more difficult than at the C-
terminus. In this study, the acylation of N-terminus of Dbzg or Dibg using in situ 
reagents such as PyAOP, HOAt, or HATU only gave low coupling yields after 
prolonged reaction time. To overcome the difficulties in acylation of sterically hindered 
ααAAs, pre-formed amino acid symmetrical anhydrides were employed as a means to 
extend the peptide chain. It was observed that symmetrical anhydrides were efficient 
reagents for acylation of N-terminus of highly hindered ααAAs in non-polar solvents 
with the absence of base. Based on this coupling method, a potential inhibitor (AMY-1) 
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of amyloid fibril was assembled. This blocker peptide was designed based on the 
hydrophobic core Aβ16-20, where ααAAs analogues of natural amino acids in the core 
were placed at alternating sequence positions. This parallel blocker peptide has shown 
promising inhibitory activity against Aβ10-35 aggregation in phosphate buffer solution. 
The aggregation of Αβ10−35 has been dramatically reduced in the presence of AMY-1 at 
either room temperature or 37 ºC. Currently, the aggregation study using dynamic light 
scattering (DLS) and fluorescence spectroscopy is in progress, and the results should 
further reveal the inhibitory activity as well as biophysical property of this blocker 
peptide. Potential future study includes preparation of the parallel blocker peptide  
  AMY-2:  H-Lys-Dibg-Val-Dbzg-Phe-Dpg-CONH2 
  AMY-3:  H-Dpg-Phe-Dbzg-Val-Dibg-(Lys)7-CONH2 
  AMY-4:  H-Dpg-Phe-Dbzg-Val-Dibg-Lys-CONH2 
 
without oligolysine at the C-terminus (AMY-2), and the preparation of anti-parallel 
blocker peptides with/without oligolysine (AMY-3, AMY-4). It has been reported that 
incorporation of oligolysine at the C-terminus of certain recognition sequence of 
amyloid hydrophobic core can prevent elongation of the amyloid β-structures.5.12 The 
inhibitory activities of AMY-2 will be studied and compared to AMY-1 to probe the β-
sheet blocking property of the hydrophobic core in the blocker peptide. The anti-parallel 
blocker peptides AMY-3 and AMY-4 will be studied for their binding and inhibitory 
activities against Aβ. The conformational behavior and biological activities of the 
parallel and anti-parallel blocker peptides will be compared, upon which potential 
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